FOXO1

UniProt ID: Q12778
Organism: Homo sapiens
Review Status: COMPLETE
📝 Provide Detailed Feedback

Gene Description

FOXO1 (Forkhead box protein O1) is a transcription factor of the FOXO family that functions as a key integrator of insulin/PI3K-AKT signaling with metabolic homeostasis and stress responses. FOXO1 binds to insulin response elements (IRE; 5'-TT[G/A]TTTTG-3') and DAF-16 binding elements (DBE; 5'-TT[G/A]TTTAC-3') via its conserved forkhead/winged-helix DNA-binding domain. FOXO1 is implicated in regulation of hepatic gluconeogenic gene programs (e.g., G6PC1, PCK1), though the FOXO1–PGC-1alpha interaction has been reported as indirect in PMID:17024043. FOXO1 activity is tightly regulated by post-translational modifications: AKT phosphorylation at T24/S256/S319 promotes 14-3-3 binding, nuclear export, and cytoplasmic sequestration, while stress kinases (MST1, JNK, AMPK) and deacetylation by sirtuins promote nuclear retention and transcriptional activation. FOXO1 shuttles between nucleus and cytoplasm based on metabolic and stress cues, functioning as a molecular switch for metabolic adaptation.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
IBA
GO_REF:0000033
ACCEPT
Summary: FOXO1 is established as a sequence-specific DNA-binding transcription factor that recognizes IRE and DBE motifs and regulates transcription by RNA polymerase II. Structural studies confirm the forkhead DNA-binding domain binds DNA directly (PMID:18786403). This is a core molecular function.
Reason: This is the fundamental molecular function of FOXO1 - it is a transcription factor that binds specific DNA sequences (IRE/DBE) and regulates gene expression. Extensively supported by structural, biochemical, and functional evidence.
Supporting Evidence:
PMID:18786403
Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification
PMID:37891184
FOXO1 is a forkhead box O transcription factor that binds DNA via a conserved winged-helix DBD
file:human/FOXO1/FOXO1-deep-research-falcon.md
model: Edison Scientific Literature
GO:0005634 nucleus
IBA
GO_REF:0000033
ACCEPT
Summary: FOXO1 localizes to the nucleus where it carries out its transcription factor function. Nuclear localization is well-documented and is the active state of the protein. Multiple IDA studies confirm nuclear localization.
Reason: Nuclear localization is essential for FOXO1's transcription factor function. This is where FOXO1 binds DNA and activates target genes. Supported by numerous experimental studies.
Supporting Evidence:
PMID:11311120
Ser(329) phosphorylation also decreases the ability of FKHR to stimulate gene transactivation and reduces the proportion of FKHR present in the nucleus.
PMID:12228231
Studies with GFP(1) fusion proteins indicate that Ser-256 phosphorylation is critical for nuclear exclusion of FKHR.
GO:0045722 positive regulation of gluconeogenesis
IBA
GO_REF:0000033
ACCEPT
Summary: FOXO1's role in promoting gluconeogenesis is a core evolved function, particularly in hepatocytes. Evidence supports FOXO1 involvement in gluconeogenic gene expression, while the FOXO1–PGC-1alpha interaction has been reported as indirect.
Reason: This is a core function of FOXO1 based on phylogenetic and systems-level evidence. PMID:17024043 indicates FOXO1 is not required or sufficient for PGC-1alpha-driven G6Pase reporter activation, suggesting the interaction is indirect, but FOXO1 remains implicated in gluconeogenic programs.
Supporting Evidence:
PMID:17024043
the transcription factor FOXO1 and the transcriptional co-activator PGC-1alpha act synergistically to stimulate the expression of genes in the gluconeogenesis pathway
PMID:37891184
hepatic FOXO1 (with FOXO3/4) controls gluconeogenic programs
GO:0006357 regulation of transcription by RNA polymerase II
IBA
GO_REF:0000033
ACCEPT
Summary: As a transcription factor, FOXO1 regulates transcription by RNA polymerase II. This is the fundamental biological process in which FOXO1 participates.
Reason: Core biological process annotation for a transcription factor. FOXO1 is established to regulate both activation and repression of Pol II-transcribed genes.
Supporting Evidence:
PMID:37710009
FOXO transcription factors as mediators of stress adaptation
GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding
IBA
GO_REF:0000033
ACCEPT
Summary: FOXO1 binds to specific cis-regulatory sequences (IRE and DBE motifs) in promoters of target genes. X-ray crystallography has defined the structural basis for sequence-specific DNA recognition by the forkhead domain.
Reason: Core molecular function - FOXO1 recognizes and binds specific DNA sequences in regulatory regions. The consensus sequences (DBE: 5'-TTGTTTAC-3'; IRE: 5'-TT[G/A]TTTTG-3') are well characterized.
Supporting Evidence:
PMID:18786403
Structural basis for DNA recognition by FoxO1
PMID:38466341
FOXO proteins recognize the DAF-16 family binding element (DBE; 5'-TTGTTTAC-3') with high affinity
GO:0008286 insulin receptor signaling pathway
IBA
GO_REF:0000033
ACCEPT
Summary: FOXO1 is a central downstream target of insulin receptor signaling. Insulin activates PI3K-AKT, which phosphorylates FOXO1 at T24/S256/S319, leading to 14-3-3 binding, nuclear export, and inactivation. This represents FOXO1's role as a key effector of insulin signaling.
Reason: Core biological process - FOXO1 is the main target of insulin signaling and mediates many of insulin's effects on metabolism. The insulin-AKT-FOXO1 axis is extensively characterized.
Supporting Evidence:
PMID:10358076
Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin
PMID:37891184
AKT/PKB phosphorylation at conserved FOXO1 residues Thr24, Ser256, and Ser319 creates 14-3-3 docking sites
GO:0000122 negative regulation of transcription by RNA polymerase II
IEA
GO_REF:0000108
ACCEPT
Summary: While FOXO1 is primarily known as a transcriptional activator, it can also repress transcription of certain target genes. For example, FOXO1 suppresses PDX1 expression in pancreatic beta cells and can repress PPARG during adipogenesis.
Reason: FOXO1 can function as both an activator and repressor depending on context and target gene. Repression of PDX1 and PPARG is documented. This represents a legitimate molecular function.
Supporting Evidence:
UniProt:Q12778
Acts as an inhibitor of glucose sensing in pancreatic beta cells by acting as a transcription repressor and suppressing expression of PDX1 (By similarity).
GO:0003677 DNA binding
IEA
GO_REF:0000120
ACCEPT
Summary: General DNA binding term. FOXO1 binds DNA via its forkhead domain. While accurate, this is less informative than the more specific GO:0000978 (sequence-specific DNA binding) annotation.
Reason: Correct but general. The more specific term GO:0000978 is preferred, but this annotation is not incorrect. DNA binding is fundamental to FOXO1's function.
GO:0003700 DNA-binding transcription factor activity
IEA
GO_REF:0000120
ACCEPT
Summary: FOXO1 is a DNA-binding transcription factor. This is correct but less specific than GO:0000981 (RNA polymerase II-specific) which better captures FOXO1's function.
Reason: Correct general annotation. FOXO1 is a transcription factor that binds DNA and regulates gene expression.
GO:0005634 nucleus
IEA
GO_REF:0000120
ACCEPT
Summary: Duplicate of IBA annotation for nucleus. FOXO1 localizes to nucleus where it functions.
Reason: Correct cellular component annotation. Nuclear localization is well-established for FOXO1.
GO:0005654 nucleoplasm
IEA
GO_REF:0000117
ACCEPT
Summary: FOXO1 is present in the nucleoplasm where it functions as a transcription factor. More specific than nucleus.
Reason: Correct subcellular localization. FOXO1 functions in the nucleoplasm to regulate gene transcription.
GO:0005737 cytoplasm
IEA
GO_REF:0000120
ACCEPT
Summary: FOXO1 shuttles between nucleus and cytoplasm. Cytoplasmic localization is the inactive state, induced by insulin/AKT-mediated phosphorylation and 14-3-3 binding. This is part of the regulatory mechanism controlling FOXO1 activity.
Reason: Correct - cytoplasmic localization is a key aspect of FOXO1 regulation. AKT phosphorylation promotes nuclear export and cytoplasmic sequestration.
Supporting Evidence:
PMID:11237865
insulin-like growth factor (IGF)-1 and serum-induced nuclear exclusion of FKHR[S256A] depends on the degree of overexpression of this mutant.
GO:0006355 regulation of DNA-templated transcription
IEA
GO_REF:0000002
ACCEPT
Summary: General term for transcription regulation. FOXO1 regulates transcription of its target genes.
Reason: Correct general annotation for a transcription factor.
GO:0006914 autophagy
IEA
GO_REF:0000043
MARK AS OVER ANNOTATED
Summary: FOXO1 can promote autophagy through both transcription-dependent (activating autophagy genes like ATG12, BNIP3, LC3) and transcription-independent mechanisms (cytosolic interaction with ATG7). However, this represents a downstream effect of FOXO1's transcription factor activity rather than its core evolved function.
Reason: While FOXO1 can transcriptionally activate autophagy-related genes and has been shown to interact with ATG7 in the cytoplasm, autophagy regulation is a downstream consequence of FOXO1's stress response program rather than its primary evolved function. FOXO1's core role is metabolic regulation; autophagy induction is one of many pleiotropic effects. The direct cytosolic ATG7 interaction (PMID:20543840) represents a non-canonical mechanism.
Supporting Evidence:
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy
GO:0006915 apoptotic process
IEA
GO_REF:0000043
KEEP AS NON CORE
Summary: FOXO1 can promote apoptosis by transcriptionally activating pro-apoptotic genes (FASLG, BIM/BCL2L11, NOXA). This is a consequence of its stress-responsive transcription factor activity.
Reason: FOXO1 does regulate apoptosis through transcription of pro-apoptotic genes, particularly under stress conditions. However, this is a downstream pleiotropic effect rather than the core evolved function (gluconeogenesis/metabolic regulation). Valid but non-core.
Supporting Evidence:
PMID:31063815
Moreover, CyPA induced FoxO1-dependent expression of downstream genes involved in EC chemotaxis and apoptosis, including monocyte chemoattractant protein-1 and BCL-2-interacting mediator of cell death, and stimulated the apoptosis of human umbilical vein ECs in vitro.
GO:0008013 beta-catenin binding
IEA
GO_REF:0000117
ACCEPT
Summary: FOXO1 interacts with beta-catenin. This interaction has functional consequences for FOXO1-dependent transcription and may relieve autoinhibition of the DNA-binding domain.
Reason: Beta-catenin binding is documented and functionally relevant. IDA evidence also exists for this interaction (PMID:15905404).
Supporting Evidence:
PMID:15905404
Functional interaction between beta-catenin and FOXO in oxidative stress signaling
PMID:37710009
β-catenin can relieve autoinhibition of the DBD
GO:0030154 cell differentiation
IEA
GO_REF:0000043
MARK AS OVER ANNOTATED
Summary: FOXO1 influences various differentiation processes including adipogenesis (negative regulation), myogenesis, and osteoblast differentiation. This is a broad pleiotropic effect rather than a specific core function.
Reason: "Cell differentiation" is too broad and vague. While FOXO1 does influence differentiation in multiple cell types, this is a downstream consequence of its transcriptional regulatory function rather than a core evolved function. More specific annotations (e.g., negative regulation of fat cell differentiation) are preferable.
GO:0043565 sequence-specific DNA binding
IEA
GO_REF:0000120
ACCEPT
Summary: FOXO1 binds DNA in a sequence-specific manner, recognizing IRE and DBE consensus sequences.
Reason: Core molecular function - sequence-specific DNA binding is fundamental to FOXO1's transcription factor activity.
GO:0005515 protein binding
IPI
PMID:11237865
Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphoryla...
MODIFY
Summary: This reference documents FOXO1 interaction with 14-3-3 proteins (YWHAG, YWHAZ). This is a functionally important interaction that mediates nuclear export after AKT phosphorylation.
Reason: While FOXO1 does bind proteins, "protein binding" is uninformative. The 14-3-3 interaction is functionally critical but should be annotated to a more specific term if available (e.g., 14-3-3 protein binding or phosphoserine/phosphothreonine binding protein interaction).
Proposed replacements: 14-3-3 protein binding
Supporting Evidence:
PMID:11237865
Thr-24 phosphorylation alone is critical for interaction with 14-3-3 proteins
GO:0005515 protein binding
IPI
PMID:11353774
Forkhead homologue in rhabdomyosarcoma functions as a bifunc...
MODIFY
Summary: Reference describes FOXO1 functioning as a nuclear receptor coactivator/corepressor.
Reason: "Protein binding" is uninformative. The interaction with nuclear receptors could be more specifically annotated as nuclear receptor coactivator activity or similar.
Supporting Evidence:
PMID:11353774
2001 May 15. Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions.
GO:0005515 protein binding
IPI
PMID:15084259
Integration of Smad and forkhead pathways
MODIFY
Summary: Reference describes integration of Smad and forkhead pathways - FOXO1 interacts with Smad proteins.
Reason: Smad binding would be more informative than generic protein binding.
Proposed replacements: R-SMAD binding
Supporting Evidence:
PMID:15084259
Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation.
GO:0005515 protein binding
IPI
PMID:15220471
Silent information regulator 2 potentiates Foxo1-mediated tr...
MODIFY
Summary: Reference documents FOXO1 interaction with SIRT1. SIRT1 deacetylates FOXO1 and potentiates its transcriptional activity.
Reason: The SIRT1 interaction is functionally important. A more specific term would be informative.
Proposed replacements: identical protein binding
Supporting Evidence:
PMID:15220471
Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity
GO:0005515 protein binding
IPI
PMID:15692560
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated...
MODIFY
Summary: Reference describes FOXO1 interaction with FHL2 and SIRT1-mediated deacetylation.
Reason: Generic protein binding annotation should be made more specific.
Proposed replacements: identical protein binding
Supporting Evidence:
PMID:15692560
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation.
GO:0005515 protein binding
IPI
PMID:18235501
DBC1 is a negative regulator of SIRT1
ACCEPT
Summary: Reference documents DBC1 as a negative regulator of SIRT1, affecting FOXO1 indirectly.
Reason: The interaction data is valid even if the generic term is uninformative.
Supporting Evidence:
PMID:18235501
DBC1 is a negative regulator of SIRT1.
GO:0005515 protein binding
IPI
PMID:18408765
CDK1 promotes cell proliferation and survival via phosphoryl...
MODIFY
Summary: Reference describes CDK1 phosphorylation and inhibition of FOXO1.
Reason: Could be more specifically annotated as kinase binding or protein serine/threonine kinase activity.
Proposed replacements: cyclin binding
Supporting Evidence:
PMID:18408765
CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor.
GO:0005515 protein binding
IPI
PMID:18786403
Structural basis for DNA recognition by FoxO1
ACCEPT
Summary: Reference is the structural study of FOXO1 DNA binding domain and its regulation by PTMs.
Reason: Valid protein binding evidence from structural study.
Supporting Evidence:
PMID:18786403
Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification.
GO:0005515 protein binding
IPI
PMID:24419615
Crystallization and preliminary X-ray analysis of a complex ...
ACCEPT
Summary: Reference describes crystallization of FOXO1/ETS1 DNA-binding complex.
Reason: Valid protein-protein interaction evidence.
Supporting Evidence:
PMID:24419615
Crystallization and preliminary X-ray analysis of a complex of the FOXO1 and Ets1 DNA-binding domains and DNA.
GO:0005515 protein binding
IPI
PMID:24983498
Inhibition of FoxO1 acetylation by INHAT subunit SET/TAF-Iβ ...
ACCEPT
Summary: Reference describes FOXO1 interaction with SET/TAF-Ibeta (INHAT subunit).
Reason: Valid interaction data.
Supporting Evidence:
PMID:24983498
Epub 2014 Jun 28. Inhibition of FoxO1 acetylation by INHAT subunit SET/TAF-Iβ induces p21 transcription.
GO:0005515 protein binding
IPI
PMID:25241761
Using an in situ proximity ligation assay to systematically ...
ACCEPT
Summary: Large-scale proximity ligation assay study of protein-protein interactions.
Reason: High-throughput interaction data, acceptable as supporting evidence.
Supporting Evidence:
PMID:25241761
Oct 9. Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.
GO:0005515 protein binding
IPI
PMID:25609649
Proteomic analyses reveal distinct chromatin-associated and ...
ACCEPT
Summary: Proteomic study of chromatin-associated transcription factor complexes.
Reason: Valid high-throughput interaction data.
Supporting Evidence:
PMID:25609649
Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome
ACCEPT
Summary: Large-scale human interactome mapping study.
Reason: Valid high-throughput interaction data.
Supporting Evidence:
PMID:28514442
Architecture of the human interactome defines protein communities and disease networks.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
ACCEPT
Summary: Dual proteome-scale network study of human interactome.
Reason: Valid high-throughput interaction data.
Supporting Evidence:
PMID:33961781
2021 May 6. Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
GO:0005515 protein binding
IPI
PMID:35271311
OpenCell: Endogenous tagging for the cartography of human ce...
ACCEPT
Summary: OpenCell study using endogenous tagging for cellular organization mapping.
Reason: Valid high-throughput interaction and localization data.
Supporting Evidence:
PMID:35271311
2022 Mar 11. OpenCell: Endogenous tagging for the cartography of human cellular organization.
GO:0005515 protein binding
IPI
PMID:35512704
Systematic discovery of mutation-directed neo-protein-protei...
ACCEPT
Summary: Study of mutation-directed neo-protein-protein interactions in cancer.
Reason: Valid interaction data.
Supporting Evidence:
PMID:35512704
2022 May 4. Systematic discovery of mutation-directed neo-protein-protein interactions in cancer.
GO:0005515 protein binding
IPI
PMID:36931259
A central chaperone-like role for 14-3-3 proteins in human c...
MODIFY
Summary: Study describing 14-3-3 proteins as central chaperones with FOXO1 as a client.
Reason: This specifically documents 14-3-3 binding which should be annotated more specifically.
Proposed replacements: 14-3-3 protein binding
Supporting Evidence:
PMID:36931259
A central chaperone-like role for 14-3-3 proteins in human cells.
GO:0000785 chromatin
IEA
GO_REF:0000107
ACCEPT
Summary: FOXO1 associates with chromatin when functioning as a transcription factor. Recent evidence suggests FOXOs can act as pioneer factors to open condensed chromatin.
Reason: FOXO1 binds to chromatin at target gene promoters. This is consistent with its transcription factor function.
Supporting Evidence:
PMID:37710009
FOXO family members can act as pioneer factors to open condensed chromatin
GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding
IEA
GO_REF:0000107
ACCEPT
Summary: Duplicate of IBA annotation. FOXO1 binds to specific cis-regulatory sequences.
Reason: Core molecular function annotation.
GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific
IEA
GO_REF:0000107
ACCEPT
Summary: FOXO1 can function as a transcriptional repressor for certain genes (e.g., PDX1, PPARG).
Reason: Valid molecular function - FOXO1 has documented repressor activity for specific target genes.
Supporting Evidence:
UniProt:Q12778
Acts as an inhibitor of glucose sensing in pancreatic beta cells by acting as a transcription repressor and suppressing expression of PDX1 (By similarity).
GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific
IEA
GO_REF:0000107
ACCEPT
Summary: FOXO1's primary function is as a transcriptional activator of target genes involved in metabolism, stress responses, and cell cycle regulation; its gluconeogenic role is supported in context, with an indirect FOXO1–PGC-1alpha interaction reported.
Reason: Core molecular function - FOXO1 is primarily a transcriptional activator.
Supporting Evidence:
PMID:17024043
FOXO1 and the transcriptional co-activator PGC-1alpha act synergistically to stimulate the expression of genes in the gluconeogenesis pathway
GO:0006357 regulation of transcription by RNA polymerase II
IEA
GO_REF:0000107
ACCEPT
Summary: Duplicate annotation. FOXO1 regulates Pol II-mediated transcription.
Reason: Core biological process for a transcription factor.
GO:0006974 DNA damage response
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: FOXO1 participates in DNA damage response by activating genes involved in DNA repair and cell cycle arrest. This is part of its broader stress response function.
Reason: FOXO1 does contribute to DNA damage response through transcriptional regulation of relevant genes, but this is a downstream effect of its stress-responsive transcription factor activity rather than its primary evolved function (gluconeogenesis).
Supporting Evidence:
PMID:37891184
FOXO1 activates genes involved in DNA repair and stress resistance
GO:0008286 insulin receptor signaling pathway
IEA
GO_REF:0000107
ACCEPT
Summary: Duplicate of IBA annotation. FOXO1 is a key component of insulin signaling.
Reason: Core biological process - FOXO1 is the main transcriptional target of insulin-PI3K-AKT signaling.
GO:0031490 chromatin DNA binding
IEA
GO_REF:0000107
ACCEPT
Summary: FOXO1 binds to DNA within chromatin context at target gene promoters and enhancers.
Reason: Specific subtype of DNA binding that accurately describes how FOXO1 functions in the cell.
GO:0032869 cellular response to insulin stimulus
IEA
GO_REF:0000107
ACCEPT
Summary: FOXO1 mediates cellular responses to insulin - it is phosphorylated and inactivated by the insulin-stimulated PI3K-AKT pathway.
Reason: Core function - FOXO1's regulation by insulin is central to its role in metabolic homeostasis.
Supporting Evidence:
PMID:10358076
Insulin disrupts IRS-dependent transactivation by FKHR
GO:0034599 cellular response to oxidative stress
IEA
GO_REF:0000107
ACCEPT
Summary: FOXO1 is activated by and mediates cellular responses to oxidative stress. Oxidative stress promotes FOXO1 nuclear localization and transcriptional activation of antioxidant genes.
Reason: Core function - oxidative stress response is one of FOXO1's primary evolved roles alongside metabolic regulation. FOXOs are described as "mediators of stress adaptation."
Supporting Evidence:
PMID:37710009
FOXO transcription factors as mediators of stress adaptation
GO:0045599 negative regulation of fat cell differentiation
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: FOXO1 inhibits adipogenesis by repressing PPARG expression. This is a documented function in adipocyte biology.
Reason: Valid annotation with experimental support. FOXO1 does negatively regulate adipogenesis, but this is a tissue-specific function rather than the core evolved function (gluconeogenesis in liver). Mark as non-core.
Supporting Evidence:
UniProt:Q12778
Regulates the expression of adipogenic genes such as PPARG during preadipocyte differentiation
GO:0045722 positive regulation of gluconeogenesis
IEA
GO_REF:0000107
ACCEPT
Summary: Duplicate of IBA annotation. Core function of FOXO1.
Reason: Core function - regulation of gluconeogenesis is FOXO1's primary evolved metabolic role.
GO:0045944 positive regulation of transcription by RNA polymerase II
IEA
GO_REF:0000107
ACCEPT
Summary: FOXO1 activates transcription of target genes. This is its primary molecular activity.
Reason: Core biological process - FOXO1 is primarily a transcriptional activator.
GO:0046676 negative regulation of insulin secretion
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: FOXO1 can negatively regulate insulin secretion in pancreatic beta cells through suppression of PDX1 expression.
Reason: This is a tissue-specific function in beta cells, not the core evolved function. Valid but non-core.
Supporting Evidence:
UniProt:Q12778
Acts as an inhibitor of glucose sensing in pancreatic beta cells
GO:0051721 protein phosphatase 2A binding
IEA
GO_REF:0000107
ACCEPT
Summary: FOXO1 interacts with PP2A (via PPP2R1A subunit). PP2A dephosphorylates FOXO1 at T24 and S256, promoting nuclear import.
Reason: Valid molecular function - PP2A interaction is important for FOXO1 regulation.
Supporting Evidence:
UniProt:Q12778
Interacts with RUNX2; the interaction inhibits RUNX2 transcriptional activity and mediates the IGF1/insulin- dependent BGLAP expression in osteoblasts Interacts with PPP2R1A; the interaction regulates the dephosphorylation of FOXO1 at Thr-24 and Ser- 256 leading to its nuclear import
GO:0070542 response to fatty acid
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: FOXO1 responds to fatty acids and regulates lipid metabolism genes. In chondrogenic commitment, FOXO1 responds to low lipid levels.
Reason: Valid but represents a context-specific response rather than core function. FOXO1's role in lipid sensing is secondary to its primary metabolic function in gluconeogenesis.
Supporting Evidence:
UniProt:Q12778
key regulator of chondrogenic commitment of skeletal progenitor cells in response to lipid availability
GO:0071732 cellular response to nitric oxide
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: FOXO1 mediates cellular responses to nitric oxide, including transcriptional activation of DNA repair genes in beta cells.
Reason: Valid stress response function but represents one of many stress stimuli that activate FOXO1 rather than a core evolved function.
Supporting Evidence:
UniProt:Q12778
Regulates the transcriptional activity of GADD45A and repair of nitric oxide-damaged DNA in beta-cells
GO:1990841 promoter-specific chromatin binding
IEA
GO_REF:0000107
ACCEPT
Summary: FOXO1 binds to chromatin at specific promoters of target genes.
Reason: Accurate molecular function describing how FOXO1 engages chromatin at target gene promoters.
GO:0005654 nucleoplasm
IDA
GO_REF:0000052
ACCEPT
Summary: Immunofluorescence data showing FOXO1 in nucleoplasm.
Reason: Direct experimental evidence for nucleoplasm localization.
GO:0005829 cytosol
IDA
GO_REF:0000052
ACCEPT
Summary: Immunofluorescence data showing FOXO1 in cytosol.
Reason: Direct experimental evidence. Cytosolic localization is the inactive, phosphorylated state.
GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific
IDA
PMID:28851713
SCP4 promotes gluconeogenesis through FoxO1/3a dephosphoryla...
ACCEPT
Summary: SCP4 dephosphorylates FOXO1, promoting gluconeogenesis. This demonstrates FOXO1's transcriptional activator function.
Reason: Core molecular function with direct experimental evidence.
Supporting Evidence:
PMID:28851713
SCP4 Promotes Gluconeogenesis Through FoxO1/3a Dephosphorylation.
GO:0005515 protein binding
IPI
PMID:28851713
SCP4 promotes gluconeogenesis through FoxO1/3a dephosphoryla...
ACCEPT
Summary: FOXO1 interaction with SCP4 phosphatase.
Reason: Valid protein-protein interaction.
Supporting Evidence:
PMID:28851713
SCP4 Promotes Gluconeogenesis Through FoxO1/3a Dephosphorylation.
GO:0005634 nucleus
IDA
PMID:28851713
SCP4 promotes gluconeogenesis through FoxO1/3a dephosphoryla...
ACCEPT
Summary: Direct assay showing nuclear localization.
Reason: Direct experimental evidence for nuclear localization.
Supporting Evidence:
PMID:28851713
SCP4 Promotes Gluconeogenesis Through FoxO1/3a Dephosphorylation.
GO:0005515 protein binding
IPI
PMID:19483080
C terminus of Hsc70-interacting protein promotes smooth musc...
MODIFY
Summary: FOXO1 interaction with STUB1/CHIP E3 ligase.
Reason: Could be more specifically annotated as ubiquitin ligase binding.
Proposed replacements: ubiquitin protein ligase binding
Supporting Evidence:
PMID:19483080
2009 May 29. C terminus of Hsc70-interacting protein promotes smooth muscle cell proliferation and survival through ubiquitin-mediated degradation of FoxO1.
GO:0034393 positive regulation of smooth muscle cell apoptotic process
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: FOXO1 promotes apoptosis in smooth muscle cells through transcriptional activation of pro-apoptotic genes.
Reason: Tissue-specific function. FOXO1 can promote apoptosis but this is a downstream effect rather than core function. Valid but non-core.
Supporting Evidence:
PMID:19483080
overexpression of CHIP repressed FoxO1-mediated transactivation and its proapoptotic function following tumor necrosis factor-alpha treatment.
GO:0060260 regulation of transcription initiation by RNA polymerase II
ISS
GO_REF:0000024
ACCEPT
Summary: FOXO1 regulates transcription initiation at target gene promoters.
Reason: Appropriate biological process term for a transcription factor.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-5692779
ACCEPT
Summary: MAPKAPK5 phosphorylates FOXO1 in nucleoplasm.
Reason: Supported by Reactome pathway annotation.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-5692785
ACCEPT
Summary: Phosphorylated FOXO1 binds RAG gene in nucleoplasm.
Reason: Supported by Reactome pathway annotation.
GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific
IDA
PMID:17024043
Gluconeogenesis: re-evaluating the FOXO1-PGC-1alpha connecti...
MARK AS OVER ANNOTATED
Summary: PMID:17024043 is a comment re-evaluating the FOXO1–PGC-1alpha model and does not provide direct experimental evidence for FOXO1 transcriptional activation.
Reason: The abstract reports FOXO1 is neither required nor sufficient for PGC-1alpha-driven G6Pase reporter activation and that the FOXO1–PGC-1alpha interaction is indirect, so this PMID alone is not strong IDA support for transcription activator activity.
Supporting Evidence:
PMID:17024043
FOXO1 is neither required nor sufficient for the stimulation of G6Pase-luciferase fusion gene expression by PGC-1alpha
GO:0005634 nucleus
IDA
PMID:25009184
Tumor suppressor p53 cooperates with SIRT6 to regulate gluco...
ACCEPT
Summary: p53 and SIRT6 cooperate to regulate FOXO1 nuclear localization and gluconeogenesis.
Reason: Direct experimental evidence for nuclear localization.
Supporting Evidence:
PMID:25009184
Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion.
GO:0005737 cytoplasm
IDA
PMID:25009184
Tumor suppressor p53 cooperates with SIRT6 to regulate gluco...
ACCEPT
Summary: SIRT6-mediated deacetylation promotes FOXO1 cytoplasmic translocation.
Reason: Direct experimental evidence showing cytoplasmic localization after SIRT6 deacetylation.
Supporting Evidence:
PMID:25009184
whose interaction with FoxO1 leads to FoxO1 deacetylation and export to the cytoplasm.
GO:0045722 positive regulation of gluconeogenesis
IDA
PMID:17024043
Gluconeogenesis: re-evaluating the FOXO1-PGC-1alpha connecti...
MARK AS OVER ANNOTATED
Summary: PMID:17024043 re-evaluates the FOXO1–PGC-1alpha connection and reports FOXO1 is not required or sufficient for PGC-1alpha-driven G6Pase reporter activation.
Reason: This comment does not provide direct evidence that FOXO1 positively regulates gluconeogenesis; it instead reports an indirect FOXO1–PGC-1alpha interaction and lack of requirement for FOXO1 in PGC-1alpha-driven G6Pase reporter activity.
Supporting Evidence:
PMID:17024043
FOXO1 is neither required nor sufficient for the stimulation of G6Pase-luciferase fusion gene expression by PGC-1alpha
GO:0045722 positive regulation of gluconeogenesis
IDA
PMID:25009184
Tumor suppressor p53 cooperates with SIRT6 to regulate gluco...
ACCEPT
Summary: SIRT6 inhibits FOXO1-mediated gluconeogenesis by promoting nuclear exclusion.
Reason: Additional evidence for FOXO1's core gluconeogenic function.
Supporting Evidence:
PMID:25009184
Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion.
GO:0046676 negative regulation of insulin secretion
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: FOXO1 inhibits insulin secretion in beta cells.
Reason: Tissue-specific function in pancreatic beta cells, not core evolved function.
GO:0003676 nucleic acid binding
EXP
PMID:18786403
Structural basis for DNA recognition by FoxO1
ACCEPT
Summary: Structural study demonstrating FOXO1's DNA binding activity.
Reason: General term but supported by structural evidence. More specific terms also present.
Supporting Evidence:
PMID:18786403
Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification.
GO:0003700 DNA-binding transcription factor activity
IDA
PMID:17024043
Gluconeogenesis: re-evaluating the FOXO1-PGC-1alpha connecti...
MARK AS OVER ANNOTATED
Summary: PMID:17024043 discusses FOXO1 in the context of gluconeogenic gene regulation but provides limited direct evidence for transcription factor activity.
Reason: This comment focuses on re-evaluating the FOXO1–PGC-1alpha relationship and reports an indirect interaction; it is not primary experimental evidence of FOXO1 transcription factor activity.
Supporting Evidence:
PMID:17024043
Gluconeogenesis: re-evaluating the FOXO1-PGC-1alpha connection.
GO:0003700 DNA-binding transcription factor activity
IMP
PMID:31063815
Cyclophilin A-FoxO1 signaling pathway in endothelial cell ap...
ACCEPT
Summary: Cyclophilin A-FOXO1 signaling in endothelial cell apoptosis demonstrates FOXO1's transcription factor activity.
Reason: Mutant phenotype evidence for transcription factor function.
Supporting Evidence:
PMID:31063815
May 4. Cyclophilin A-FoxO1 signaling pathway in endothelial cell apoptosis.
GO:0005515 protein binding
IPI
PMID:31063815
Cyclophilin A-FoxO1 signaling pathway in endothelial cell ap...
ACCEPT
Summary: FOXO1 interacts with cyclophilin A (PPIA).
Reason: Valid protein-protein interaction.
Supporting Evidence:
PMID:31063815
May 4. Cyclophilin A-FoxO1 signaling pathway in endothelial cell apoptosis.
GO:0005634 nucleus
IDA
PMID:31063815
Cyclophilin A-FoxO1 signaling pathway in endothelial cell ap...
ACCEPT
Summary: Nuclear localization demonstrated in endothelial cell study.
Reason: Direct experimental evidence.
Supporting Evidence:
PMID:31063815
May 4. Cyclophilin A-FoxO1 signaling pathway in endothelial cell apoptosis.
GO:0005737 cytoplasm
IDA
PMID:31063815
Cyclophilin A-FoxO1 signaling pathway in endothelial cell ap...
ACCEPT
Summary: Cytoplasmic localization in endothelial cells.
Reason: Direct experimental evidence.
Supporting Evidence:
PMID:31063815
May 4. Cyclophilin A-FoxO1 signaling pathway in endothelial cell apoptosis.
GO:0006915 apoptotic process
IMP
PMID:31063815
Cyclophilin A-FoxO1 signaling pathway in endothelial cell ap...
KEEP AS NON CORE
Summary: FOXO1 regulates endothelial cell apoptosis through transcription of BCL2L11.
Reason: Valid annotation showing FOXO1's role in apoptosis, but this is a downstream effect of transcriptional regulation rather than core function.
Supporting Evidence:
PMID:31063815
Moreover, CyPA induced FoxO1-dependent expression of downstream genes involved in EC chemotaxis and apoptosis, including monocyte chemoattractant protein-1 and BCL-2-interacting mediator of cell death, and stimulated the apoptosis of human umbilical vein ECs in vitro.
GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific
ISS
GO_REF:0000024
ACCEPT
Summary: Sequence similarity-based evidence for transcriptional activator function.
Reason: Core function supported by multiple evidence types.
GO:0070542 response to fatty acid
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: FOXO1 responds to fatty acid levels.
Reason: Context-specific response, not core function.
GO:0000785 chromatin
ISA
GO_REF:0000113
ACCEPT
Summary: TFClass database annotation for chromatin association.
Reason: Valid cellular component annotation.
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
ISA
GO_REF:0000113
ACCEPT
Summary: TFClass database annotation for Pol II transcription factor activity.
Reason: Core molecular function.
GO:1903243 negative regulation of cardiac muscle hypertrophy in response to stress
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: FOXO1 can inhibit cardiac hypertrophy.
Reason: Tissue-specific function in heart. Valid but not core function.
Supporting Evidence:
UniProt:Q12778
Mediates the function of MLIP in cardiomyocytes hypertrophy and cardiac remodeling
GO:0045944 positive regulation of transcription by RNA polymerase II
IMP
PMID:27577745
MARCH1 regulates insulin sensitivity by controlling cell sur...
ACCEPT
Summary: MARCH1 study showing FOXO1's transcriptional activation function.
Reason: Core biological process.
Supporting Evidence:
PMID:27577745
MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels.
GO:0008013 beta-catenin binding
IDA
PMID:15905404
Functional interaction between beta-catenin and FOXO in oxid...
ACCEPT
Summary: Direct evidence for FOXO1-beta-catenin interaction in oxidative stress signaling.
Reason: Direct experimental evidence for specific protein-protein interaction.
Supporting Evidence:
PMID:15905404
Functional interaction between beta-catenin and FOXO in oxidative stress signaling
GO:0005515 protein binding
IPI
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy ...
ACCEPT
Summary: FOXO1 interacts with ATG7 in cytoplasm for autophagy induction.
Reason: Valid protein-protein interaction data.
Supporting Evidence:
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity.
GO:0005634 nucleus
IDA
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy ...
ACCEPT
Summary: Nuclear localization in autophagy study.
Reason: Direct experimental evidence.
Supporting Evidence:
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity.
GO:0005737 cytoplasm
IDA
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy ...
ACCEPT
Summary: Cytoplasmic localization important for autophagy function.
Reason: Direct experimental evidence.
Supporting Evidence:
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity.
GO:0009267 cellular response to starvation
IDA
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy ...
ACCEPT
Summary: FOXO1 mediates cellular response to starvation/nutrient deprivation.
Reason: Core function - FOXO1 is activated by starvation to promote gluconeogenesis and autophagy.
Supporting Evidence:
PMID:20543840
Endogenous FoxO1 was required for autophagy in human cancer cell lines in response to oxidative stress or serum starvation, but this process was independent of the transcriptional activity of FoxO1.
GO:0010508 positive regulation of autophagy
IMP
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy ...
KEEP AS NON CORE
Summary: FOXO1 promotes autophagy through both transcriptional and non-transcriptional mechanisms.
Reason: Valid but represents a downstream stress response rather than core function. The core function is metabolic regulation.
Supporting Evidence:
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy
GO:0031625 ubiquitin protein ligase binding
IPI
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy ...
ACCEPT
Summary: FOXO1 interacts with ubiquitin E3 ligases including STUB1/CHIP.
Reason: Valid molecular function relevant to FOXO1 regulation.
Supporting Evidence:
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity.
GO:0043065 positive regulation of apoptotic process
IMP
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy ...
KEEP AS NON CORE
Summary: FOXO1 promotes apoptosis under stress conditions.
Reason: Valid but downstream effect of FOXO1's transcriptional activity rather than core function.
Supporting Evidence:
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity.
GO:0045732 positive regulation of protein catabolic process
IMP
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy ...
KEEP AS NON CORE
Summary: FOXO1 promotes protein catabolism through autophagy induction.
Reason: Downstream effect of autophagy induction, not core function.
Supporting Evidence:
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity.
GO:0071455 cellular response to hyperoxia
IDA
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy ...
ACCEPT
Summary: FOXO1 responds to oxidative stress including hyperoxia.
Reason: Part of FOXO1's stress response function.
Supporting Evidence:
PMID:20543840
Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity.
GO:0032869 cellular response to insulin stimulus
ISS
GO_REF:0000024
ACCEPT
Summary: Duplicate annotation for insulin response.
Reason: Core function.
GO:0045599 negative regulation of fat cell differentiation
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: FOXO1 inhibits adipogenesis.
Reason: Tissue-specific function, not core.
GO:0005829 cytosol
TAS
Reactome:R-HSA-211178
ACCEPT
Summary: Phosphorylated FOXO1 is excluded from nucleus and found in cytosol.
Reason: Valid localization annotation.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9614414
ACCEPT
Summary: AKT-phosphorylated FOXO translocates to cytosol.
Reason: Valid localization.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9614423
ACCEPT
Summary: 14-3-3 binds phosphorylated FOXO1 in cytosol.
Reason: Valid localization.
GO:0005739 mitochondrion
ISS
PMID:22510882
Novel repressor regulates insulin sensitivity through intera...
UNDECIDED
Summary: Some evidence for mitochondrial localization of FOXO1.
Reason: Mitochondrial localization of FOXO1 is not well-established. The primary localizations are nucleus and cytoplasm. This may represent a minor or context-specific localization. Need more evidence.
Supporting Evidence:
PMID:22510882
Novel repressor regulates insulin sensitivity through interaction with Foxo1.
GO:0005634 nucleus
IDA
PMID:18680538
GAS6-induced signaling in human endothelial cells is mediate...
ACCEPT
Summary: Nuclear localization evidence.
Reason: Direct evidence for nuclear localization.
Supporting Evidence:
PMID:18680538
GAS6-induced signaling in human endothelial cells is mediated by FOXO1a.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-199299
ACCEPT
Summary: AKT phosphorylates FOXO transcription factors in nucleoplasm.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-211164
ACCEPT
Summary: AKT phosphorylates FOXO1A in nucleoplasm.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-211178
ACCEPT
Summary: Phosphorylated FOXO1A is excluded from the nucleus.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2399992
ACCEPT
Summary: AKT1 E17K mutant phosphorylates FOXO transcription factors.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6790036
ACCEPT
Summary: STAT3-upregulated nuclear proteins including FOXO.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-9614414
ACCEPT
Summary: AKT-phosphorylated FOXOs translocate to cytosol.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-9614662
ACCEPT
Summary: FOXO1 binds FASLG gene promoter.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-9617840
ACCEPT
Summary: FOXO1 binds CDKN1A gene promoter.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-9617996
ACCEPT
Summary: FOXO1 binds SMAD2/3:SMAD4 complex.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-9622980
ACCEPT
Summary: FOXO1 binds NPY gene promoter.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-9623415
ACCEPT
Summary: FOXO1 binds IGFBP1 gene promoter.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-9624976
ACCEPT
Summary: FOXO1 binds CAV1 gene promoter.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-9625091
ACCEPT
Summary: FOXO1 binds ABCA6 gene promoter.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-9626928
ACCEPT
Summary: CREBBP binds FOXO1.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-NUL-9620806
ACCEPT
Summary: FOXO1 binds Rbl2 gene.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-NUL-9620857
ACCEPT
Summary: FOXO1 binds Ccng2 gene.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-NUL-9624599
ACCEPT
Summary: FOXO1 binds Fbxo32 gene promoter.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-NUL-9625492
ACCEPT
Summary: FOXO1 and Smad2/3:Smad4 bind Mstn gene promoter.
Reason: Supported by Reactome pathway.
GO:0005654 nucleoplasm
TAS
Reactome:R-NUL-9625758
ACCEPT
Summary: FOXO1 and SMAD3 bind Trim63 gene promoter.
Reason: Supported by Reactome pathway.
GO:0006974 DNA damage response
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: FOXO1 participates in DNA damage response.
Reason: Downstream stress response, not core function.
GO:0071732 cellular response to nitric oxide
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: FOXO1 responds to nitric oxide.
Reason: Stress response, not core function.
GO:0034599 cellular response to oxidative stress
ISS
GO_REF:0000024
ACCEPT
Summary: FOXO1 responds to oxidative stress.
Reason: Core function - oxidative stress response is one of FOXO1's primary evolved roles.
GO:0051721 protein phosphatase 2A binding
ISS
GO_REF:0000024
ACCEPT
Summary: PP2A binding for FOXO1 dephosphorylation.
Reason: Valid molecular function.
GO:0005515 protein binding
IPI
PMID:15890677
The coactivator p300 directly acetylates the forkhead transc...
MODIFY
Summary: FOXO1 interacts with p300 coactivator.
Reason: Should be annotated more specifically.
Supporting Evidence:
PMID:15890677
May 12. The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription.
GO:0001659 temperature homeostasis
ISS
PMID:22510882
Novel repressor regulates insulin sensitivity through intera...
KEEP AS NON CORE
Summary: FOXO1 role in temperature homeostasis through metabolic regulation.
Reason: Downstream physiological effect, not core molecular function.
Supporting Evidence:
PMID:22510882
Novel repressor regulates insulin sensitivity through interaction with Foxo1.
GO:0001678 intracellular glucose homeostasis
ISS
PMID:22510882
Novel repressor regulates insulin sensitivity through intera...
ACCEPT
Summary: FOXO1 regulates glucose homeostasis through gluconeogenic gene transcription.
Reason: Core function - glucose homeostasis is central to FOXO1's evolved role.
Supporting Evidence:
PMID:37891184
hepatic FOXO1 controls gluconeogenic programs
PMID:22510882
Novel repressor regulates insulin sensitivity through interaction with Foxo1.
GO:0003682 chromatin binding
ISS
PMID:22510882
Novel repressor regulates insulin sensitivity through intera...
ACCEPT
Summary: FOXO1 binds chromatin at target gene promoters.
Reason: Valid molecular function for a transcription factor.
Supporting Evidence:
PMID:22510882
Novel repressor regulates insulin sensitivity through interaction with Foxo1.
GO:0005829 cytosol
ISS
PMID:22510882
Novel repressor regulates insulin sensitivity through intera...
ACCEPT
Summary: Cytosolic localization.
Reason: Valid cellular component annotation.
Supporting Evidence:
PMID:22510882
Novel repressor regulates insulin sensitivity through interaction with Foxo1.
GO:0006473 protein acetylation
ISS
PMID:22510882
Novel repressor regulates insulin sensitivity through intera...
MARK AS OVER ANNOTATED
Summary: FOXO1 is acetylated; its acetylation status regulates activity.
Reason: This term implies FOXO1 has acetyltransferase activity, which is incorrect. FOXO1 is a substrate of acetylation, not an enzyme that performs acetylation. The annotation should be removed or replaced with a term about being modified by acetylation.
Supporting Evidence:
PMID:22510882
Novel repressor regulates insulin sensitivity through interaction with Foxo1.
GO:0009267 cellular response to starvation
ISS
PMID:22510882
Novel repressor regulates insulin sensitivity through intera...
ACCEPT
Summary: FOXO1 responds to starvation by promoting gluconeogenesis.
Reason: Core function - starvation response through gluconeogenesis is central to FOXO1.
Supporting Evidence:
PMID:22510882
Novel repressor regulates insulin sensitivity through interaction with Foxo1.
GO:0045444 fat cell differentiation
ISS
PMID:22510882
Novel repressor regulates insulin sensitivity through intera...
KEEP AS NON CORE
Summary: FOXO1 regulates adipogenesis.
Reason: Tissue-specific function, not core. FOXO1 inhibits rather than promotes this process.
Supporting Evidence:
PMID:22510882
Novel repressor regulates insulin sensitivity through interaction with Foxo1.
GO:0045892 negative regulation of DNA-templated transcription
ISS
PMID:22510882
Novel repressor regulates insulin sensitivity through intera...
ACCEPT
Summary: FOXO1 can repress transcription of certain genes.
Reason: Valid biological process - FOXO1 acts as repressor for some targets.
Supporting Evidence:
PMID:22510882
Novel repressor regulates insulin sensitivity through interaction with Foxo1.
GO:0070417 cellular response to cold
ISS
PMID:22510882
Novel repressor regulates insulin sensitivity through intera...
KEEP AS NON CORE
Summary: FOXO1 role in cold response through metabolic adaptation.
Reason: Downstream physiological effect, not core molecular function.
Supporting Evidence:
PMID:22510882
Novel repressor regulates insulin sensitivity through interaction with Foxo1.
GO:0097009 energy homeostasis
ISS
PMID:22510882
Novel repressor regulates insulin sensitivity through intera...
ACCEPT
Summary: FOXO1 regulates energy homeostasis through metabolic gene transcription.
Reason: Core function - energy/metabolic homeostasis is central to FOXO1.
Supporting Evidence:
PMID:22510882
Novel repressor regulates insulin sensitivity through interaction with Foxo1.
GO:0005737 cytoplasm
IDA
PMID:11237865
Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphoryla...
ACCEPT
Summary: Cytoplasmic localization with 14-3-3 binding.
Reason: Direct experimental evidence.
Supporting Evidence:
PMID:11237865
Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting.
GO:0008286 insulin receptor signaling pathway
ISS
GO_REF:0000024
ACCEPT
Summary: FOXO1 in insulin signaling.
Reason: Core function.
GO:0032873 negative regulation of stress-activated MAPK cascade
IDA
PMID:19696738
FoxM1, a critical regulator of oxidative stress during oncog...
UNDECIDED
Summary: FoxM1 paper - may be mislabeled for FOXO1.
Reason: The cited reference PMID:19696738 is about FoxM1, not FOXO1. This may be an annotation error. Need verification.
Supporting Evidence:
PMID:19696738
FoxM1, a critical regulator of oxidative stress during oncogenesis.
GO:0005515 protein binding
IPI
PMID:17030088
APPL1, APPL2, Akt2 and FOXO1a interact with FSHR
ACCEPT
Summary: FOXO1 interacts with APPL1, APPL2, AKT2 in FSH receptor complex.
Reason: Valid protein-protein interaction data.
Supporting Evidence:
PMID:17030088
Epub 2006 Oct 9. APPL1, APPL2, Akt2 and FOXO1a interact with FSHR in a potential signaling complex.
GO:0005634 nucleus
IDA
PMID:11311120
The kinase DYRK1A phosphorylates the transcription factor FK...
ACCEPT
Summary: DYRK1A phosphorylation study showing nuclear FOXO1.
Reason: Direct experimental evidence.
Supporting Evidence:
PMID:11311120
Ser(329) phosphorylation also decreases the ability of FKHR to stimulate gene transactivation and reduces the proportion of FKHR present in the nucleus.
GO:0005634 nucleus
IDA
PMID:12228231
Phosphorylation of serine 256 suppresses transactivation by ...
ACCEPT
Summary: Phosphorylation study showing nuclear localization.
Reason: Direct experimental evidence.
Supporting Evidence:
PMID:12228231
2002 Sep 12. Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms.
GO:0005737 cytoplasm
IDA
PMID:11311120
The kinase DYRK1A phosphorylates the transcription factor FK...
ACCEPT
Summary: Cytoplasmic localization after phosphorylation.
Reason: Direct experimental evidence.
Supporting Evidence:
PMID:11311120
The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site.
GO:0005737 cytoplasm
IDA
PMID:12228231
Phosphorylation of serine 256 suppresses transactivation by ...
ACCEPT
Summary: Cytoplasmic localization after insulin stimulation.
Reason: Direct experimental evidence.
Supporting Evidence:
PMID:12228231
2002 Sep 12. Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms.
GO:0043066 negative regulation of apoptotic process
IDA
PMID:10871843
Transcriptional modulation of the anti-apoptotic protein BCL...
UNDECIDED
Summary: PAX3/FKHR fusion study - shows FOXO1 can have anti-apoptotic effects in certain contexts.
Reason: This reference is about PAX3-FKHR fusion protein in rhabdomyosarcoma, not wild-type FOXO1 function. The annotation may be misleading as FOXO1 is generally pro-apoptotic. Need clarification.
Supporting Evidence:
PMID:10871843
Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR.
GO:0043565 sequence-specific DNA binding
IDA
PMID:12228231
Phosphorylation of serine 256 suppresses transactivation by ...
ACCEPT
Summary: Direct evidence for sequence-specific DNA binding from phosphorylation study.
Reason: Core molecular function with direct evidence.
Supporting Evidence:
PMID:12228231
Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms.
GO:0045893 positive regulation of DNA-templated transcription
IDA
PMID:10871843
Transcriptional modulation of the anti-apoptotic protein BCL...
ACCEPT
Summary: PAX3/FKHR study showing transcriptional activation.
Reason: Direct evidence for transcriptional activation function.
Supporting Evidence:
PMID:10871843
Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR.
GO:0045893 positive regulation of DNA-templated transcription
IDA
PMID:12228231
Phosphorylation of serine 256 suppresses transactivation by ...
ACCEPT
Summary: Evidence for FOXO1 transcriptional activation function.
Reason: Core biological process.
Supporting Evidence:
PMID:12228231
2002 Sep 12. Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms.
GO:0045893 positive regulation of DNA-templated transcription
IDA
PMID:7862145
The PAX3-FKHR fusion protein created by the t(2;13) transloc...
ACCEPT
Summary: Early PAX3-FKHR fusion study showing transcriptional activation.
Reason: Early evidence for FOXO1's transactivation domain function.
Supporting Evidence:
PMID:7862145
The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3.
GO:0045944 positive regulation of transcription by RNA polymerase II
IDA
PMID:10871843
Transcriptional modulation of the anti-apoptotic protein BCL...
ACCEPT
Summary: Evidence for Pol II-mediated transcription activation.
Reason: Core biological process.
Supporting Evidence:
PMID:10871843
Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR.
GO:0045944 positive regulation of transcription by RNA polymerase II
IDA
PMID:12228231
Phosphorylation of serine 256 suppresses transactivation by ...
ACCEPT
Summary: Evidence for Pol II-mediated transcription activation.
Reason: Core biological process.
Supporting Evidence:
PMID:12228231
2002 Sep 12. Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms.

Core Functions

FOXO1 is a sequence-specific DNA-binding transcription factor that binds to insulin response elements (IRE; 5'-TT[G/A]TTTTG-3') and DAF-16 binding elements (DBE; 5'-TT[G/A]TTTAC-3') via its conserved forkhead/winged-helix domain to regulate transcription of target genes.

FOXO1 is the main downstream effector of insulin signaling through the PI3K-AKT pathway. Insulin-activated AKT phosphorylates FOXO1 at T24/S256/S319, promoting 14-3-3 binding, nuclear export, and transcriptional inactivation. This represents FOXO1's role as the transcriptional switch for insulin signaling.

FOXO1 mediates cellular adaptation to oxidative stress by translocating to the nucleus and activating transcription of antioxidant and stress resistance genes. This represents one of FOXO1's primary evolved functions alongside metabolic regulation.

References

Gene Ontology annotation through association of InterPro records with GO terms
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
Gene Ontology annotation based on curation of immunofluorescence data
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Automatic assignment of GO terms using logical inference, based on on inter-ontology links
Gene Ontology annotation of human sequence-specific DNA binding transcription factors (DbTFs) based on the TFClass database
Electronic Gene Ontology annotations created by ARBA machine learning models
Combined Automated Annotation using Multiple IEA Methods
Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR
  • FOXO1 binds to IRE consensus sequence and is suppressed by insulin-activated AKT
Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR.
Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting.
  • AKT phosphorylation of T24/S256/S319 promotes 14-3-3 binding and nuclear export
The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site.
  • FOXO1 is largely nuclear in unstimulated cells
Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions.
Phosphorylation of serine 256 suppresses transactivation by FKHR
  • Ser256 phosphorylation decreases DNA binding and promotes nuclear exclusion
Integration of Smad and forkhead pathways
Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity.
  • SIRT1 deacetylates FOXO1 and enhances transcriptional activity
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation
The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription.
  • p300/CBP acetylate FOXO1 and modulate its activity
Functional interaction between beta-catenin and FOXO in oxidative stress signaling
  • Beta-catenin interacts with FOXO1 and modulates oxidative stress response
Gluconeogenesis: re-evaluating the FOXO1-PGC-1alpha connection
  • The original model proposed FOXO1 and PGC-1alpha act synergistically to stimulate gluconeogenic gene expression.
    "FOXO1 and the transcriptional co-activator PGC-1alpha act synergistically to stimulate the expression of genes in the gluconeogenesis pathway"
  • This report finds FOXO1 is neither required nor sufficient for PGC-1alpha-driven activation of G6Pase reporter expression.
    "FOXO1 is neither required nor sufficient for the stimulation of G6Pase-luciferase fusion gene expression by PGC-1alpha"
  • The data indicate the FOXO1–PGC-1alpha transcriptional interaction is indirect.
    "the transcriptional interaction between FOXO1 and PGC-1alpha is indirect"
APPL1, APPL2, Akt2 and FOXO1a interact with FSHR
DBC1 is a negative regulator of SIRT1
Activation of FOXO1 by Cdk1
  • CDK1 phosphorylates FOXO1 at Ser249
CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor.
GAS6-induced signaling in human endothelial cells is mediated by FOXO1a.
Structural basis for DNA recognition by FoxO1
  • X-ray crystallography of FOXO1 DNA-binding domain
C terminus of Hsc70-interacting protein promotes smooth muscle cell proliferation and survival through ubiquitin-mediated degradation of FoxO1.
  • STUB1/CHIP ubiquitinates and degrades FOXO1
FoxM1, a critical regulator of oxidative stress during oncogenesis.
Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity.
  • Acetylated cytosolic FOXO1 interacts with ATG7 to promote autophagy
Novel repressor regulates insulin sensitivity through interaction with Foxo1.
Crystallization and preliminary X-ray analysis of a complex of the FOXO1 and Ets1 DNA-binding domains and DNA.
Inhibition of FoxO1 acetylation by INHAT subunit SET/TAF-Iβ induces p21 transcription.
Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion.
  • SIRT6 deacetylates FOXO1 at K423 promoting cytoplasmic translocation
Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.
Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.
MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor
Architecture of the human interactome
SCP4 promotes gluconeogenesis through FoxO1/3a dephosphorylation
Cyclophilin A-FoxO1 signaling pathway in endothelial cell apoptosis.
  • PPIA promotes FOXO1 dephosphorylation and nuclear accumulation
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
OpenCell: Endogenous tagging for the cartography of human cellular organization.
Systematic discovery of mutation-directed neo-protein-protein interactions
A central chaperone-like role for 14-3-3 proteins in human cells.
The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3.
santos2023foxofamilyisoforms
FOXO family isoforms
  • FOXO1 is a forkhead box O transcription factor with conserved winged-helix DBD
  • AKT phosphorylation creates 14-3-3 binding sites driving nuclear export
cheng2024forkheadboxo
Forkhead box O proteins - steering the course of stem cell fate
  • FOXO proteins recognize DBE (5'-TTGTTTAC-3') with high affinity
rodriguezcolman2024foxotranscriptionfactors
FOXO transcription factors as mediators of stress adaptation
  • FOXOs can act as pioneer factors to open condensed chromatin
  • PTM code determines context-specific genome engagement
Reactome:R-HSA-199299
AKT phosphorylates FOXO transcription factors
Reactome:R-HSA-211164
AKT phosphorylates FOXO1A
Reactome:R-HSA-211178
Phosphorylated FOXO1A is excluded from the nucleus
Reactome:R-HSA-2399992
AKT1 E17K mutant phosphorylates forkhead box transcription factors
Reactome:R-HSA-5692779
p-T182 MAPKAPK5 phosphorylates FOXO1
Reactome:R-HSA-5692785
p-S215 FOXO1 binds RAG gene
Reactome:R-HSA-6790036
Expression of STAT3-upregulated nuclear proteins
Reactome:R-HSA-9614414
AKT-phosphorylated FOXO1,FOXO3,FOXO4 translocate to the cytosol
Reactome:R-HSA-9614423
14-3-3 proteins bind AKT-phosphorylated FOXO1
Reactome:R-HSA-9614662
FOXO1,FOXO3,(FOXO4) bind FASLG gene promoter
Reactome:R-HSA-9617840
FOXO1,FOXO3,FOXO4 bind CDKN1A gene promoter
Reactome:R-HSA-9617996
FOXO1,FOXO3,FOXO4 bind p-2S-SMAD2/3:SMAD4
Reactome:R-HSA-9622980
FOXO1 binds NPY gene promoter
Reactome:R-HSA-9623415
FOXO1,FOXO3,FOXO4 bind IGFBP1 gene promoter
Reactome:R-HSA-9624976
FOXO1,FOXO3 binds CAV1 gene promoter
Reactome:R-HSA-9625091
FOXO1,FOXO3 bind ABCA6 gene promoter
Reactome:R-HSA-9626928
CREBBP binds FOXO1
Reactome:R-NUL-9620806
FOXO1,FOXO3 binds Rbl2 gene
Reactome:R-NUL-9620857
FOXO1,FOXO3 binds Ccng2 gene
Reactome:R-NUL-9624599
FOXO1 binds Fbxo32 gene promoter
Reactome:R-NUL-9625492
FOXO1 and p-2S-Smad2/3:Smad4 bind Mstn gene promoter
Reactome:R-NUL-9625758
FOXO1,FOXO3 and SMAD3 bind Trim63 gene promoter
file:human/FOXO1/FOXO1-deep-research-falcon.md
Deep research report on FOXO1

Suggested Questions for Experts

Q: Is there evidence for isoform-specific functions of FOXO1 versus FOXO3/FOXO4 in specific tissues, particularly in hepatic gluconeogenesis versus other metabolic processes?

Q: What is the relative contribution of FOXO1's transcriptional versus non-transcriptional (cytoplasmic ATG7 interaction) roles in autophagy regulation?

Suggested Experiments

Experiment: ChIP-seq comparison of FOXO1 binding sites in fed versus fasted hepatocytes to define the core gluconeogenic gene regulatory program.

Experiment: Structure-function analysis of FOXO1 acetylation sites to determine which modifications are essential for transcription factor activity versus autophagy induction.

📚 Additional Documentation

Deep Research Falcon

(FOXO1-deep-research-falcon.md)

provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-01-18T22:35:36.894108'
end_time: '2026-01-18T22:44:37.485022'
duration_seconds: 540.59
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: FOXO1
gene_symbol: FOXO1
uniprot_accession: Q12778
protein_description: 'RecName: Full=Forkhead box protein O1 {ECO:0000305}; AltName:
Full=Forkhead box protein O1A; AltName: Full=Forkhead in rhabdomyosarcoma {ECO:0000303|PubMed:8275086};'
gene_info: Name=FOXO1 {ECO:0000303|PubMed:12228231, ECO:0000312|HGNC:HGNC:3819};
Synonyms=FKHR {ECO:0000303|PubMed:9479491}, FOXO1A;
organism_full: Homo sapiens (Human).
protein_family: Not specified in UniProt
protein_domains: FH_FOXO1. (IPR047408); Fork_head_dom. (IPR001766); FOXO-TAD. (IPR032067);
FOXO_KIX-bd. (IPR032068); TF_fork_head_CS_2. (IPR030456)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 32


Question

Gene Research for Functional Annotation

⚠ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

  • UniProt Accession: Q12778
  • Protein Description: RecName: Full=Forkhead box protein O1 {ECO:0000305}; AltName: Full=Forkhead box protein O1A; AltName: Full=Forkhead in rhabdomyosarcoma {ECO:0000303|PubMed:8275086};
  • Gene Information: Name=FOXO1 {ECO:0000303|PubMed:12228231, ECO:0000312|HGNC:HGNC:3819}; Synonyms=FKHR {ECO:0000303|PubMed:9479491}, FOXO1A;
  • Organism (full): Homo sapiens (Human).
  • Protein Family: Not specified in UniProt
  • Key Domains: FH_FOXO1. (IPR047408); Fork_head_dom. (IPR001766); FOXO-TAD. (IPR032067); FOXO_KIX-bd. (IPR032068); TF_fork_head_CS_2. (IPR030456)

MANDATORY VERIFICATION STEPS:

  1. Check if the gene symbol "FOXO1" matches the protein description above
  2. Verify the organism is correct: Homo sapiens (Human).
  3. Check if protein family/domains align with what you find in literature
  4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'FOXO1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene FOXO1 (gene ID: FOXO1, UniProt: Q12778) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Gene Research for Functional Annotation

⚠ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

  • UniProt Accession: Q12778
  • Protein Description: RecName: Full=Forkhead box protein O1 {ECO:0000305}; AltName: Full=Forkhead box protein O1A; AltName: Full=Forkhead in rhabdomyosarcoma {ECO:0000303|PubMed:8275086};
  • Gene Information: Name=FOXO1 {ECO:0000303|PubMed:12228231, ECO:0000312|HGNC:HGNC:3819}; Synonyms=FKHR {ECO:0000303|PubMed:9479491}, FOXO1A;
  • Organism (full): Homo sapiens (Human).
  • Protein Family: Not specified in UniProt
  • Key Domains: FH_FOXO1. (IPR047408); Fork_head_dom. (IPR001766); FOXO-TAD. (IPR032067); FOXO_KIX-bd. (IPR032068); TF_fork_head_CS_2. (IPR030456)

MANDATORY VERIFICATION STEPS:

  1. Check if the gene symbol "FOXO1" matches the protein description above
  2. Verify the organism is correct: Homo sapiens (Human).
  3. Check if protein family/domains align with what you find in literature
  4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'FOXO1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene FOXO1 (gene ID: FOXO1, UniProt: Q12778) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan and verification
We verified the target identity and nomenclature: FOXO1 (UniProt Q12778) encodes the human Forkhead box protein O1 (aliases: FKHR/FOXO1A), a FOXO-family transcription factor with a conserved forkhead (winged-helix) DNA-binding domain, nuclear localization and export signals, and a C-terminal transactivation domain; these match the UniProt domain annotations (Fork_head_dom, FOXO-TAD, KIX-binding interface) and recent structural reviews (2023–2024) (santos2023foxofamilyisoforms pages 4-6, cheng2024forkheadboxo pages 3-4, rodriguezcolman2024foxotranscriptionfactors pages 2-3).

Comprehensive research report: FOXO1 (human; UniProt Q12778)

1) Key concepts and definitions with current understanding
- Molecular identity and domains: FOXO1 is a forkhead box O transcription factor that binds DNA via a conserved winged-helix DBD whose recognition helix (H3) targets FOXO motifs; the protein is largely intrinsically disordered outside the DBD and contains conserved CR1/CR2/CR3 regions that mediate interactions with co-regulators (e.g., CBP/p300) and an activation domain (TAD). An overlapping NLS/NES controls nuclear–cytoplasmic shuttling (santos2023foxofamilyisoforms pages 4-6, cheng2024forkheadboxo pages 3-4).
- Consensus DNA motifs: FOXO proteins recognize the DAF-16 family binding element (DBE; 5′-TTGTTTAC-3′) with high affinity, and also bind insulin-responsive elements (IREs); FOXO1 predominantly binds as a monomer to these motifs, though dimeric binding to palindromic sites has been described (cheng2024forkheadboxo pages 3-4, rodriguezcolman2024foxotranscriptionfactors pages 2-3).
- Biochemical role: FOXO1 functions as a transcriptional regulator integrating nutrient, insulin/PI3K–AKT, and stress signaling to control programs of metabolism (e.g., gluconeogenesis), autophagy, cell cycle arrest, and stress resistance. FOXO family members can act as pioneer factors to open condensed chromatin, and CR3/CR2 can autoinhibit the DBD, relieved by cofactor binding (e.g., β-catenin) (rodriguezcolman2024foxotranscriptionfactors pages 2-3, santos2023foxofamilyisoforms pages 12-13).
- Post-translational modifications (PTMs) and localization control:
• AKT/PKB phosphorylation at conserved FOXO1 residues Thr24, Ser256, and Ser319 creates 14‑3‑3 docking sites, driving CRM1-dependent nuclear export and cytosolic sequestration (and promoting degradation under sustained insulin signaling) (santos2023foxofamilyisoforms pages 6-7, cheng2024forkheadboxo pages 3-4, rodriguezcolman2024foxotranscriptionfactors pages 2-3).
• Additional kinases modulate FOXO1: AMPK, JNK, p38, MST1 often promote nuclear localization/activation under stress; ERK, CK1, CDK2, IKK can negatively regulate activity or stability in a context-dependent manner (cheng2024forkheadboxo pages 3-4, santos2023foxofamilyisoforms pages 6-7, rodriguezcolman2024foxotranscriptionfactors pages 2-3).
• Acetylation/deacetylation: CBP/p300 acetylate FOXO1 lysines within the regulatory region (e.g., K245, K248, K262, K265), modulating DNA binding and transactivation, while sirtuin deacetylases (e.g., SIRT family) deacetylate FOXOs to tune activity and target gene selection (santos2023foxofamilyisoforms pages 6-7, asadi2025foxosandtheir pages 2-4).
• Ubiquitylation: FOXO ubiquitylation states correlate with localization and stability; monoubiquitylation can favor nuclear import, whereas polyubiquitylation drives proteasomal degradation. E3s such as MDM2/SKP2 and DUBs like USP7 are implicated across FOXOs (rodriguezcolman2024foxotranscriptionfactors pages 2-3, asadi2025foxosandtheir pages 2-4).
• 14-3-3 and nuclear transport: AKT-site phosphorylation generates 14‑3‑3 binding that masks the NLS and exposes the NES, enabling CRM1-dependent export; conversely, stress kinases and redox cues promote nuclear import via importins (cheng2024forkheadboxo pages 3-4, rodriguezcolman2024foxotranscriptionfactors pages 2-3).

2) Recent developments and latest research (emphasis 2023–2024)
- Engineered T cells and immunotherapy: Two independent studies established FOXO1 as a master regulator of human CAR T cell memory and metabolic fitness. In Nature (2024), FOXO1 inhibition or gene editing impaired memory programs and antitumor function, while FOXO1 overexpression enforced a memory-like state, increased chromatin accessibility at FOXO motifs, preserved function under chronic stimulation, and improved in vivo persistence and tumor control; notably, TCF1 overexpression did not substitute for FOXO1, underscoring FOXO1’s unique role (published online April 10, 2024; https://doi.org/10.1038/s41586-024-07300-8) (doan2024foxo1isa pages 1-2). A 2023 preprint similarly reported that FOXO1 overexpression enhanced memory markers (CD62L, IL7R), suppressed exhaustion programs, and improved metabolic fitness and tumor control, whereas FOXO1 inhibition had the opposite effects (posted Nov 2023; https://doi.org/10.21203/rs.3.rs-2802998/v1) (mackall2023foxo1isa pages 6-8).
- FOXO1 in metabolism: Isoform-focused review synthesis indicates hepatic FOXO1 (with FOXO3/4) controls gluconeogenic programs; combined hepatic deletion of FOXO1/3/4 in mice reduces blood glucose and insulin with improved insulin sensitivity. FOXO1 can interact with PPARα to attenuate FGF21 induction, linking FOXO1 to systemic fuel metabolism and endocrine signaling (2023; https://doi.org/10.1038/s41419-023-06177-1) (santos2023foxofamilyisoforms pages 12-13). Mechanistic overviews in 2024 detail how PI3K–AKT phosphorylation drives nuclear exclusion, while stress kinases (JNK/p38/MST1/AMPK) promote nuclear FOXO activation during fasting/stress, consistent with FOXO1’s role in gluconeogenesis and autophagy (cheng2024forkheadboxo pages 3-4, rodriguezcolman2024foxotranscriptionfactors pages 2-3).
- Endothelial biology and angiogenesis: State-of-the-art reviews in 2024 synthesize that FOXOs (including FOXO1) restrain endothelial proliferation and regulate metabolic state, with insulin/AKT inhibition of FOXOs shifting endothelial programs and stress kinases promoting nuclear FOXO entry under oxidative stress; redox-dependent importin interactions (e.g., TNPO1/IPO7/8 pathways) facilitate nuclear import under oxidative cues (2024; https://doi.org/10.1038/s41580-023-00649-0) (rodriguezcolman2024foxotranscriptionfactors pages 2-3) and outline the NLS/NES-based shuttling critical to endothelium (cheng2024forkheadboxo pages 3-4).
- Fusion-positive alveolar rhabdomyosarcoma (ARMS): Recent narrative and mechanistic reviews consolidate that PAX3–FOXO1 and PAX7–FOXO1 are pathognomonic drivers of fusion-positive ARMS, functioning as pioneer-like oncoproteins that establish super-enhancers and reprogram the myogenic transcriptional circuitry (MYOD1, MYOG, MYCN) with extensive chromatin binding and enhancer–promoter looping via CBP/p300, BRD4, and Mediator dependency (2025 synthesis of the 2017–2024 literature; https://doi.org/10.3390/ijms26115204, May 2025) (ziemba2025moleculartargetsin pages 2-4, ziemba2025moleculartargetsin pages 4-6). Fusion status is prognostic and diagnostic (detected in ~70–80% of ARMS) and correlates with aggressive disease; fusion-specific antibodies can assist IHC-based detection (ziemba2025moleculartargetsin pages 1-2, ziemba2025moleculartargetsin pages 48-50). While direct fusion targeting remains elusive, preclinical dependencies and strategies include epigenetic modulators (BET inhibitors), cell-cycle kinase inhibitors (CDK4/6, Aurora A), and newly proposed vulnerabilities (e.g., metabolic DHFR dependency leading to methotrexate sensitivity) summarized in 2025 (ziemba2025moleculartargetsin pages 45-47, ziemba2025moleculartargetsin pages 2-4, ziemba2025moleculartargetsin pages 48-50, ziemba2025moleculartargetsin pages 1-2).

3) Current applications and real-world implementations
- T cell engineering: The 2024 Nature study highlights a translational strategy—genetic FOXO1 overexpression in CAR T products—to enforce a memory-like state, enhance persistence and tumor control, and potentially improve outcomes; the work also associates endogenous FOXO1 activity with clinical responses in patients treated with CAR T or TILs (online April 10, 2024; https://doi.org/10.1038/s41586-024-07300-8) (doan2024foxo1isa pages 1-2). The 2023 preprint similarly proposes FOXO1 modulation as an engineering knob for next-generation cell therapies (Nov 2023; https://doi.org/10.21203/rs.3.rs-2802998/v1) (mackall2023foxo1isa pages 6-8).
- Diagnostics/prognostics in ARMS: Reviews summarize clinical adoption of fusion testing (FISH/RT-PCR/NGS) and fusion-junction antibodies for subclassification, risk stratification, and monitoring; fusion positivity is integrated into modern ARMS risk schemas (synthesized 2025; https://doi.org/10.3390/ijms26115204) (ziemba2025moleculartargetsin pages 1-2, ziemba2025moleculartargetsin pages 4-6).

4) Expert opinions and analysis from authoritative sources
- Nature Reviews perspective (2024) emphasizes FOXOs as central stress-adaptation transcription factors with pioneer activity, regulated by a combinatorial PTM code (phosphorylation, acetylation, ubiquitin states) and co-regulator interactions that determine context-specific genome engagement and transcriptional outcomes (Sep 2024; https://doi.org/10.1038/s41580-023-00649-0) (rodriguezcolman2024foxotranscriptionfactors pages 2-3).
- Cross-isoform structural/functional analysis (2023) underscores shared architecture with isoform-specific IDR features; provides curated site-level PTMs in FOXO1 (AKT sites T24/S256/S319; multiple kinase sites; acetyl-lysines; PRMT1 arginine methylation), and highlights therapeutic angles (isoform-selective 14‑3‑3 interactions; protein–protein interaction disruptors; PROTACs) (Oct 2023; https://doi.org/10.1038/s41419-023-06177-1) (santos2023foxofamilyisoforms pages 6-7, santos2023foxofamilyisoforms pages 12-13).
- Cell Regeneration (2024) delineates canonical DNA motifs (DBE vs IRE), NLS/NES mechanisms, and broad kinase/deacetylase regulation in mammalian FOXOs with specific attention to stem cell contexts (Mar 2024; https://doi.org/10.1186/s13619-024-00190-1) (cheng2024forkheadboxo pages 3-4, cheng2024forkheadboxo pages 1-3).

5) Relevant statistics and data from recent studies
- CAR T engineering: FOXO1 overexpression in human CAR T cells increased memory-associated gene programs and improved tumor control in vivo; FOXO1 inhibition reduced memory markers (e.g., CD62L/SELL, IL7R) and increased exhaustion markers (e.g., PD-1/TOX family), with impaired antitumor activity. FOXO1 activity correlated with positive outcomes in patients receiving CAR T/TILs (Nature, online April 10, 2024; https://doi.org/10.1038/s41586-024-07300-8) (doan2024foxo1isa pages 1-2). Concordant preprint data in Nov 2023 documented enhanced OXPHOS/metabolic fitness and serial-stimulation resilience with FOXO1 overexpression, and reduced persistence/efficacy with FOXO1 inhibition (https://doi.org/10.21203/rs.3.rs-2802998/v1) (mackall2023foxo1isa pages 6-8).
- Metabolic regulation: Genetic ablation studies summarized in 2023 show combined liver FOXO1/3/4 deletion reduces blood glucose/insulin and improves insulin sensitivity, indicating synergistic control of gluconeogenesis; FOXO1’s attenuation of PPARα-driven FGF21 links FOXO1 to systemic metabolic endocrine responses (Oct 2023; https://doi.org/10.1038/s41419-023-06177-1) (santos2023foxofamilyisoforms pages 12-13).
- ARMS fusion epidemiology and prognosis: Fusion-positive ARMS is defined by PAX3/7–FOXO1 fusions in ~70–80% of cases, with fusion status linked to aggressive clinical behavior and poorer survival, establishing fusion testing as critical for risk stratification (compiled 2025; https://doi.org/10.3390/ijms26115204) (ziemba2025moleculartargetsin pages 1-2).

Mechanistic framework: regulation, localization, and partners
- Phospho-switch for trafficking: AKT/SGK phosphorylation on FOXO1 T24/S256/S319 recruits 14‑3‑3, masks the NLS and reveals the NES, enabling CRM1 export and cytoplasmic sequestration; dephosphorylation or stress-kinase inputs (JNK/p38/MST1/AMPK) favor nuclear import and transcriptional activation (cheng2024forkheadboxo pages 3-4, santos2023foxofamilyisoforms pages 6-7, rodriguezcolman2024foxotranscriptionfactors pages 2-3).
- Acetylation code: p300/CBP acetylation on FOXO1 K245/K248/K262/K265 dampens DNA binding/altered cofactor recruitment, while sirtuin deacetylation (e.g., SIRT family) re-sensitizes FOXOs and influences target selection (santos2023foxofamilyisoforms pages 6-7, asadi2025foxosandtheir pages 2-4).
- Ubiquitin-state control: Monoubiquitylation favors nuclear import and transcriptional competence, polyubiquitylation targets FOXO for proteasomal turnover; MDM2/SKP2 and USP7 participate in FOXO ubiquitin cycling (rodriguezcolman2024foxotranscriptionfactors pages 2-3, asadi2025foxosandtheir pages 2-4).
- Cofactor partnerships: CR3/CR2 interfaces recruit coactivators (CBP/p300, Mediator), engage β‑catenin to relieve autoinhibition, and cooperate with tissue-specific factors to specify transcriptional outcomes (rodriguezcolman2024foxotranscriptionfactors pages 2-3, cheng2024forkheadboxo pages 3-4).

Notes on scope and limitations
- RNF213-mediated K63-linked FOXO1 ubiquitination and several endothelial/metabolic primary studies from late 2024–2025 fall outside the directly citable context here. Where mechanistic components (e.g., K63 Ub and nuclear import) are discussed broadly for FOXOs, we have cited integrative 2023–2024 reviews (rodriguezcolman2024foxotranscriptionfactors pages 2-3, asadi2025foxosandtheir pages 2-4). For fusion-positive ARMS, the 2025 narrative synthesis aggregates 2017–2024 evidence (ziemba2025moleculartargetsin pages 45-47, ziemba2025moleculartargetsin pages 1-2), including super-enhancer biology and indirect targeting strategies; readers should consult the referenced URLs for detailed 2023–2024 primary citations.

References with URLs and dates
- Santos BF et al. FOXO family isoforms. Cell Death & Disease. Oct 2023. https://doi.org/10.1038/s41419-023-06177-1 (santos2023foxofamilyisoforms pages 4-6, santos2023foxofamilyisoforms pages 6-7, santos2023foxofamilyisoforms pages 12-13)
- Cheng M et al. Forkhead box O proteins: steering the course of stem cell fate. Cell Regeneration. Mar 2024. https://doi.org/10.1186/s13619-024-00190-1 (cheng2024forkheadboxo pages 3-4, cheng2024forkheadboxo pages 1-3)
- Rodriguez-Colman MJ, Dansen TB, Burgering BMT. FOXO transcription factors as mediators of stress adaptation. Nat Rev Mol Cell Biol. Sep 2024. https://doi.org/10.1038/s41580-023-00649-0 (rodriguezcolman2024foxotranscriptionfactors pages 2-3)
- Doan AE et al. FOXO1 is a master regulator of memory programming in CAR T cells. Nature. Online Apr 10, 2024. https://doi.org/10.1038/s41586-024-07300-8 (doan2024foxo1isa pages 1-2)
- Mackall CL et al. FOXO1 is a master regulator of CAR T memory programming. Research Square. Nov 2023. https://doi.org/10.21203/rs.3.rs-2802998/v1 (mackall2023foxo1isa pages 6-8)
- Ziemba B, Lukow K. Molecular targets in alveolar rhabdomyosarcoma: progress and pitfalls. Int J Mol Sci. May 2025. https://doi.org/10.3390/ijms26115204 (ziemba2025moleculartargetsin pages 45-47, ziemba2025moleculartargetsin pages 2-4, ziemba2025moleculartargetsin pages 48-50, ziemba2025moleculartargetsin pages 1-2, ziemba2025moleculartargetsin pages 4-6)
- Sankhe CS, Hall L, Kendall GC. Fusion oncogenes in rhabdomyosarcoma: mechanisms and therapeutic implications. Frontiers in Oncology. Jun 2025. https://doi.org/10.3389/fonc.2025.1570070 (sankhe2025fusiononcogenesin pages 2-4, sankhe2025fusiononcogenesin pages 1-2)
- Asadi Y et al. FOXOs and their roles in acute and chronic neurological disorders. Front Mol Biosci. Apr 2025. https://doi.org/10.3389/fmolb.2025.1538472 (asadi2025foxosandtheir pages 1-2, asadi2025foxosandtheir pages 2-4, asadi2025foxosandtheir pages 9-10)

Conclusion
Human FOXO1 (Q12778) is a stress- and nutrient-responsive transcription factor whose activity is set by a combinatorial PTM code (phosphorylation, acetylation, ubiquitylation) and nuclear shuttling via 14‑3‑3/CRM1 and importins. Recent high-impact work established FOXO1 as a tractable lever to enhance human CAR T memory, persistence, and antitumor efficacy, positioning FOXO1 modulation for near-term translational applications. In parallel, consolidated evidence underscores FOXO1’s central roles in hepatic gluconeogenesis and endothelial stress responses, and documents that PAX3/7–FOXO1 fusions drive ARMS via enhancer reprogramming with actionable cofactor dependencies. Together, these advances provide precise mechanistic targets and implementation paths—from T cell engineering knobs to fusion-positive sarcoma vulnerabilities—for FOXO1-centered interventions (doan2024foxo1isa pages 1-2, mackall2023foxo1isa pages 6-8, rodriguezcolman2024foxotranscriptionfactors pages 2-3, santos2023foxofamilyisoforms pages 12-13, ziemba2025moleculartargetsin pages 2-4).

References

  1. (santos2023foxofamilyisoforms pages 4-6): Bruno F. Santos, Inês Grenho, Paulo J. Martel, Bibiana I. Ferreira, and Wolfgang Link. Foxo family isoforms. Cell Death & Disease, Oct 2023. URL: https://doi.org/10.1038/s41419-023-06177-1, doi:10.1038/s41419-023-06177-1. This article has 88 citations and is from a peer-reviewed journal.

  2. (cheng2024forkheadboxo pages 3-4): Mengdi Cheng, Yujie Nie, Min Song, Fulin Chen, and Yuan Yu. Forkhead box o proteins: steering the course of stem cell fate. Cell Regeneration, Mar 2024. URL: https://doi.org/10.1186/s13619-024-00190-1, doi:10.1186/s13619-024-00190-1. This article has 10 citations.

  3. (rodriguezcolman2024foxotranscriptionfactors pages 2-3): Maria J. Rodriguez-Colman, Tobias B. Dansen, and Boudewijn. M. T. Burgering. Foxo transcription factors as mediators of stress adaptation. Nature Reviews Molecular Cell Biology, 25:46-64, Sep 2024. URL: https://doi.org/10.1038/s41580-023-00649-0, doi:10.1038/s41580-023-00649-0. This article has 143 citations and is from a domain leading peer-reviewed journal.

  4. (santos2023foxofamilyisoforms pages 12-13): Bruno F. Santos, Inês Grenho, Paulo J. Martel, Bibiana I. Ferreira, and Wolfgang Link. Foxo family isoforms. Cell Death & Disease, Oct 2023. URL: https://doi.org/10.1038/s41419-023-06177-1, doi:10.1038/s41419-023-06177-1. This article has 88 citations and is from a peer-reviewed journal.

  5. (santos2023foxofamilyisoforms pages 6-7): Bruno F. Santos, Inês Grenho, Paulo J. Martel, Bibiana I. Ferreira, and Wolfgang Link. Foxo family isoforms. Cell Death & Disease, Oct 2023. URL: https://doi.org/10.1038/s41419-023-06177-1, doi:10.1038/s41419-023-06177-1. This article has 88 citations and is from a peer-reviewed journal.

  6. (asadi2025foxosandtheir pages 2-4): Yasin Asadi, Rozenn K. Moundounga, Anand Chakroborty, Augustina Pokokiri, and Hongmin Wang. Foxos and their roles in acute and chronic neurological disorders. Frontiers in Molecular Biosciences, Apr 2025. URL: https://doi.org/10.3389/fmolb.2025.1538472, doi:10.3389/fmolb.2025.1538472. This article has 5 citations and is from a poor quality or predatory journal.

  7. (doan2024foxo1isa pages 1-2): Alexander E. Doan, Katherine P. Mueller, Andy Y. Chen, Geoffrey T. Rouin, Yingshi Chen, Bence Daniel, John Lattin, Martina Markovska, Brett Mozarsky, Jose Arias-Umana, Robert Hapke, In-Young Jung, Alice Wang, Peng Xu, Dorota Klysz, Gabrielle Zuern, Malek Bashti, Patrick J. Quinn, Zhuang Miao, Katalin Sandor, Wenxi Zhang, Gregory M. Chen, Faith Ryu, Meghan Logun, Junior Hall, Kai Tan, Stephan A. Grupp, Susan E. McClory, Caleb A. Lareau, Joseph A. Fraietta, Elena Sotillo, Ansuman T. Satpathy, Crystal L. Mackall, and Evan W. Weber. Foxo1 is a master regulator of memory programming in car t cells. Nature, 629:211-218, Apr 2024. URL: https://doi.org/10.1038/s41586-024-07300-8, doi:10.1038/s41586-024-07300-8. This article has 162 citations and is from a highest quality peer-reviewed journal.

  8. (mackall2023foxo1isa pages 6-8): Crystal L. Mackall, Alexander E Doan, Katherine P Mueller, Andy Y. Chen, Geoffrey T. Rouin, Bence Daniel, John Lattin, Yingshi Chen, Brett Mozarsky, M. Markovska, Jose Arias-Umana, Robert Hapke, Inyoung Jung, Peng Xu, D. Klysz, Malek Bashti, Patrick Quinn, Katalin D. Sandor, Wenxi Zhang, Junior Hall, Caleb A. Lareau, Stephan A. Grupp, J. Fraietta, E. Sotillo, Ansuman T. Satpathy, and Evan W. Weber. Foxo1 is a master regulator of car t memory programming. Research Square, Nov 2023. URL: https://doi.org/10.21203/rs.3.rs-2802998/v1, doi:10.21203/rs.3.rs-2802998/v1. This article has 10 citations.

  9. (ziemba2025moleculartargetsin pages 2-4): Barbara Ziemba and Klaudia Lukow. Molecular targets in alveolar rhabdomyosarcoma: a narrative review of progress and pitfalls. International Journal of Molecular Sciences, 26:5204, May 2025. URL: https://doi.org/10.3390/ijms26115204, doi:10.3390/ijms26115204. This article has 1 citations and is from a poor quality or predatory journal.

  10. (ziemba2025moleculartargetsin pages 4-6): Barbara Ziemba and Klaudia Lukow. Molecular targets in alveolar rhabdomyosarcoma: a narrative review of progress and pitfalls. International Journal of Molecular Sciences, 26:5204, May 2025. URL: https://doi.org/10.3390/ijms26115204, doi:10.3390/ijms26115204. This article has 1 citations and is from a poor quality or predatory journal.

  11. (ziemba2025moleculartargetsin pages 1-2): Barbara Ziemba and Klaudia Lukow. Molecular targets in alveolar rhabdomyosarcoma: a narrative review of progress and pitfalls. International Journal of Molecular Sciences, 26:5204, May 2025. URL: https://doi.org/10.3390/ijms26115204, doi:10.3390/ijms26115204. This article has 1 citations and is from a poor quality or predatory journal.

  12. (ziemba2025moleculartargetsin pages 48-50): Barbara Ziemba and Klaudia Lukow. Molecular targets in alveolar rhabdomyosarcoma: a narrative review of progress and pitfalls. International Journal of Molecular Sciences, 26:5204, May 2025. URL: https://doi.org/10.3390/ijms26115204, doi:10.3390/ijms26115204. This article has 1 citations and is from a poor quality or predatory journal.

  13. (ziemba2025moleculartargetsin pages 45-47): Barbara Ziemba and Klaudia Lukow. Molecular targets in alveolar rhabdomyosarcoma: a narrative review of progress and pitfalls. International Journal of Molecular Sciences, 26:5204, May 2025. URL: https://doi.org/10.3390/ijms26115204, doi:10.3390/ijms26115204. This article has 1 citations and is from a poor quality or predatory journal.

  14. (cheng2024forkheadboxo pages 1-3): Mengdi Cheng, Yujie Nie, Min Song, Fulin Chen, and Yuan Yu. Forkhead box o proteins: steering the course of stem cell fate. Cell Regeneration, Mar 2024. URL: https://doi.org/10.1186/s13619-024-00190-1, doi:10.1186/s13619-024-00190-1. This article has 10 citations.

  15. (sankhe2025fusiononcogenesin pages 2-4): Chinmay S. Sankhe, Lisa Hall, and Genevieve C. Kendall. Fusion oncogenes in rhabdomyosarcoma: model systems, mechanisms of tumorigenesis, and therapeutic implications. Frontiers in Oncology, Jun 2025. URL: https://doi.org/10.3389/fonc.2025.1570070, doi:10.3389/fonc.2025.1570070. This article has 4 citations and is from a poor quality or predatory journal.

  16. (sankhe2025fusiononcogenesin pages 1-2): Chinmay S. Sankhe, Lisa Hall, and Genevieve C. Kendall. Fusion oncogenes in rhabdomyosarcoma: model systems, mechanisms of tumorigenesis, and therapeutic implications. Frontiers in Oncology, Jun 2025. URL: https://doi.org/10.3389/fonc.2025.1570070, doi:10.3389/fonc.2025.1570070. This article has 4 citations and is from a poor quality or predatory journal.

  17. (asadi2025foxosandtheir pages 1-2): Yasin Asadi, Rozenn K. Moundounga, Anand Chakroborty, Augustina Pokokiri, and Hongmin Wang. Foxos and their roles in acute and chronic neurological disorders. Frontiers in Molecular Biosciences, Apr 2025. URL: https://doi.org/10.3389/fmolb.2025.1538472, doi:10.3389/fmolb.2025.1538472. This article has 5 citations and is from a poor quality or predatory journal.

  18. (asadi2025foxosandtheir pages 9-10): Yasin Asadi, Rozenn K. Moundounga, Anand Chakroborty, Augustina Pokokiri, and Hongmin Wang. Foxos and their roles in acute and chronic neurological disorders. Frontiers in Molecular Biosciences, Apr 2025. URL: https://doi.org/10.3389/fmolb.2025.1538472, doi:10.3389/fmolb.2025.1538472. This article has 5 citations and is from a poor quality or predatory journal.

Citations

  1. santos2023foxofamilyisoforms pages 12-13
  2. rodriguezcolman2024foxotranscriptionfactors pages 2-3
  3. cheng2024forkheadboxo pages 3-4
  4. ziemba2025moleculartargetsin pages 1-2
  5. santos2023foxofamilyisoforms pages 4-6
  6. santos2023foxofamilyisoforms pages 6-7
  7. asadi2025foxosandtheir pages 2-4
  8. ziemba2025moleculartargetsin pages 2-4
  9. ziemba2025moleculartargetsin pages 4-6
  10. ziemba2025moleculartargetsin pages 48-50
  11. ziemba2025moleculartargetsin pages 45-47
  12. cheng2024forkheadboxo pages 1-3
  13. sankhe2025fusiononcogenesin pages 2-4
  14. sankhe2025fusiononcogenesin pages 1-2
  15. asadi2025foxosandtheir pages 1-2
  16. asadi2025foxosandtheir pages 9-10
  17. https://doi.org/10.1038/s41586-024-07300-8
  18. https://doi.org/10.21203/rs.3.rs-2802998/v1
  19. https://doi.org/10.1038/s41419-023-06177-1
  20. https://doi.org/10.1038/s41580-023-00649-0
  21. https://doi.org/10.3390/ijms26115204,
  22. https://doi.org/10.3390/ijms26115204
  23. https://doi.org/10.1186/s13619-024-00190-1
  24. https://doi.org/10.3389/fonc.2025.1570070
  25. https://doi.org/10.3389/fmolb.2025.1538472
  26. https://doi.org/10.1038/s41419-023-06177-1,
  27. https://doi.org/10.1186/s13619-024-00190-1,
  28. https://doi.org/10.1038/s41580-023-00649-0,
  29. https://doi.org/10.3389/fmolb.2025.1538472,
  30. https://doi.org/10.1038/s41586-024-07300-8,
  31. https://doi.org/10.21203/rs.3.rs-2802998/v1,
  32. https://doi.org/10.3389/fonc.2025.1570070,

📄 View Raw YAML

id: Q12778
gene_symbol: FOXO1
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >
  FOXO1 (Forkhead box protein O1) is a transcription factor of the FOXO family that
  functions as a key integrator
  of insulin/PI3K-AKT signaling with metabolic homeostasis and stress responses. FOXO1
  binds to insulin response
  elements (IRE; 5'-TT[G/A]TTTTG-3') and DAF-16 binding elements (DBE; 5'-TT[G/A]TTTAC-3')
  via its conserved
  forkhead/winged-helix DNA-binding domain. FOXO1 is implicated in regulation of hepatic
  gluconeogenic
  gene programs (e.g., G6PC1, PCK1), though the FOXO1–PGC-1alpha interaction has been
  reported as indirect
  in PMID:17024043. FOXO1 activity is tightly regulated by
  post-translational modifications: AKT phosphorylation at T24/S256/S319 promotes
  14-3-3 binding, nuclear export,
  and cytoplasmic sequestration, while stress kinases (MST1, JNK, AMPK) and deacetylation
  by sirtuins promote
  nuclear retention and transcriptional activation. FOXO1 shuttles between nucleus
  and cytoplasm based on
  metabolic and stress cues, functioning as a molecular switch for metabolic adaptation.
existing_annotations:
# ====================
# IBA ANNOTATIONS (Phylogenetically inferred - high confidence baseline)
# ====================
- term:
    id: GO:0000981
    label: DNA-binding transcription factor activity, RNA polymerase II-specific
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >
      FOXO1 is established as a sequence-specific DNA-binding transcription factor
      that recognizes IRE and DBE
      motifs and regulates transcription by RNA polymerase II. Structural studies
      confirm the forkhead DNA-binding
      domain binds DNA directly (PMID:18786403). This is a core molecular function.
    action: ACCEPT
    reason: >
      This is the fundamental molecular function of FOXO1 - it is a transcription
      factor that binds specific
      DNA sequences (IRE/DBE) and regulates gene expression. Extensively supported
      by structural, biochemical,
      and functional evidence.
    supported_by:
    - reference_id: PMID:18786403
      supporting_text: "Structural basis for DNA recognition by FoxO1 and its regulation
        by posttranslational modification"
    - reference_id: PMID:37891184
      supporting_text: "FOXO1 is a forkhead box O transcription factor that binds
        DNA via a conserved winged-helix DBD"

      full_text_unavailable: true
    - reference_id: file:human/FOXO1/FOXO1-deep-research-falcon.md
      supporting_text: 'model: Edison Scientific Literature'
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >
      FOXO1 localizes to the nucleus where it carries out its transcription factor
      function. Nuclear localization
      is well-documented and is the active state of the protein. Multiple IDA studies
      confirm nuclear localization.
    action: ACCEPT
    reason: >
      Nuclear localization is essential for FOXO1's transcription factor function.
      This is where FOXO1 binds DNA
      and activates target genes. Supported by numerous experimental studies.
    supported_by:
    - reference_id: PMID:11311120
      supporting_text: "Ser(329) phosphorylation also decreases the ability of FKHR
        to stimulate gene transactivation and reduces the proportion of FKHR present
        in the nucleus."
    - reference_id: PMID:12228231
      supporting_text: "Studies with GFP(1) fusion proteins indicate that Ser-256
        phosphorylation is critical for nuclear exclusion of FKHR."

- term:
    id: GO:0045722
    label: positive regulation of gluconeogenesis
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >
      FOXO1's role in promoting gluconeogenesis is a core evolved function, particularly
      in hepatocytes.
      Evidence supports FOXO1 involvement in gluconeogenic gene expression, while
      the FOXO1–PGC-1alpha
      interaction has been reported as indirect.
    action: ACCEPT
    reason: >
      This is a core function of FOXO1 based on phylogenetic and systems-level evidence.
      PMID:17024043
      indicates FOXO1 is not required or sufficient for PGC-1alpha-driven G6Pase
      reporter activation,
      suggesting the interaction is indirect, but FOXO1 remains implicated in gluconeogenic
      programs.
    supported_by:
    - reference_id: PMID:17024043
      supporting_text: "the transcription factor FOXO1 and the transcriptional co-activator
        PGC-1alpha act synergistically to stimulate the expression of genes in the
        gluconeogenesis pathway"
    - reference_id: PMID:37891184
      supporting_text: "hepatic FOXO1 (with FOXO3/4) controls gluconeogenic programs"

      full_text_unavailable: true
- term:
    id: GO:0006357
    label: regulation of transcription by RNA polymerase II
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >
      As a transcription factor, FOXO1 regulates transcription by RNA polymerase
      II. This is the fundamental
      biological process in which FOXO1 participates.
    action: ACCEPT
    reason: >
      Core biological process annotation for a transcription factor. FOXO1 is established
      to regulate both
      activation and repression of Pol II-transcribed genes.
    supported_by:
    - reference_id: PMID:37710009
      supporting_text: "FOXO transcription factors as mediators of stress adaptation"

- term:
    id: GO:0000978
    label: RNA polymerase II cis-regulatory region sequence-specific DNA binding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >
      FOXO1 binds to specific cis-regulatory sequences (IRE and DBE motifs) in promoters
      of target genes.
      X-ray crystallography has defined the structural basis for sequence-specific
      DNA recognition by the
      forkhead domain.
    action: ACCEPT
    reason: >
      Core molecular function - FOXO1 recognizes and binds specific DNA sequences
      in regulatory regions.
      The consensus sequences (DBE: 5'-TTGTTTAC-3'; IRE: 5'-TT[G/A]TTTTG-3') are
      well characterized.
    supported_by:
    - reference_id: PMID:18786403
      supporting_text: "Structural basis for DNA recognition by FoxO1"
    - reference_id: PMID:38466341
      supporting_text: "FOXO proteins recognize the DAF-16 family binding element
        (DBE; 5'-TTGTTTAC-3') with high affinity"

      full_text_unavailable: true
- term:
    id: GO:0008286
    label: insulin receptor signaling pathway
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >
      FOXO1 is a central downstream target of insulin receptor signaling. Insulin
      activates PI3K-AKT, which
      phosphorylates FOXO1 at T24/S256/S319, leading to 14-3-3 binding, nuclear
      export, and inactivation.
      This represents FOXO1's role as a key effector of insulin signaling.
    action: ACCEPT
    reason: >
      Core biological process - FOXO1 is the main target of insulin signaling and
      mediates many of insulin's
      effects on metabolism. The insulin-AKT-FOXO1 axis is extensively characterized.
    supported_by:
    - reference_id: PMID:10358076
      supporting_text: "Phosphorylation of serine 256 by protein kinase B disrupts
        transactivation by FKHR and mediates effects of insulin"
    - reference_id: PMID:37891184
      supporting_text: "AKT/PKB phosphorylation at conserved FOXO1 residues Thr24,
        Ser256, and Ser319 creates 14-3-3 docking sites"

# ====================
# IEA ANNOTATIONS (Electronically inferred - require careful assessment)
# ====================
      full_text_unavailable: true
- term:
    id: GO:0000122
    label: negative regulation of transcription by RNA polymerase II
  evidence_type: IEA
  original_reference_id: GO_REF:0000108
  review:
    summary: >
      While FOXO1 is primarily known as a transcriptional activator, it can also
      repress transcription of
      certain target genes. For example, FOXO1 suppresses PDX1 expression in pancreatic
      beta cells and can
      repress PPARG during adipogenesis.
    action: ACCEPT
    reason: >
      FOXO1 can function as both an activator and repressor depending on context
      and target gene. Repression
      of PDX1 and PPARG is documented. This represents a legitimate molecular function.
    supported_by:
    - reference_id: UniProt:Q12778
      supporting_text: "Acts as an inhibitor of glucose sensing in pancreatic beta
        cells by acting as a transcription repressor and suppressing expression of
        PDX1 (By similarity)."

- term:
    id: GO:0003677
    label: DNA binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >
      General DNA binding term. FOXO1 binds DNA via its forkhead domain. While accurate,
      this is less
      informative than the more specific GO:0000978 (sequence-specific DNA binding)
      annotation.
    action: ACCEPT
    reason: >
      Correct but general. The more specific term GO:0000978 is preferred, but this
      annotation is not
      incorrect. DNA binding is fundamental to FOXO1's function.

- term:
    id: GO:0003700
    label: DNA-binding transcription factor activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >
      FOXO1 is a DNA-binding transcription factor. This is correct but less specific
      than GO:0000981
      (RNA polymerase II-specific) which better captures FOXO1's function.
    action: ACCEPT
    reason: >
      Correct general annotation. FOXO1 is a transcription factor that binds DNA
      and regulates gene expression.

- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >
      Duplicate of IBA annotation for nucleus. FOXO1 localizes to nucleus where
      it functions.
    action: ACCEPT
    reason: >
      Correct cellular component annotation. Nuclear localization is well-established
      for FOXO1.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: >
      FOXO1 is present in the nucleoplasm where it functions as a transcription
      factor. More specific
      than nucleus.
    action: ACCEPT
    reason: >
      Correct subcellular localization. FOXO1 functions in the nucleoplasm to regulate
      gene transcription.

- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >
      FOXO1 shuttles between nucleus and cytoplasm. Cytoplasmic localization is
      the inactive state,
      induced by insulin/AKT-mediated phosphorylation and 14-3-3 binding. This is
      part of the regulatory
      mechanism controlling FOXO1 activity.
    action: ACCEPT
    reason: >
      Correct - cytoplasmic localization is a key aspect of FOXO1 regulation. AKT
      phosphorylation promotes
      nuclear export and cytoplasmic sequestration.
    supported_by:
    - reference_id: PMID:11237865
      supporting_text: "insulin-like growth factor (IGF)-1 and serum-induced nuclear
        exclusion of FKHR[S256A] depends on the degree of overexpression of this mutant."

- term:
    id: GO:0006355
    label: regulation of DNA-templated transcription
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: >
      General term for transcription regulation. FOXO1 regulates transcription of
      its target genes.
    action: ACCEPT
    reason: >
      Correct general annotation for a transcription factor.

- term:
    id: GO:0006914
    label: autophagy
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >
      FOXO1 can promote autophagy through both transcription-dependent (activating
      autophagy genes like
      ATG12, BNIP3, LC3) and transcription-independent mechanisms (cytosolic interaction
      with ATG7).
      However, this represents a downstream effect of FOXO1's transcription factor
      activity rather than
      its core evolved function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >
      While FOXO1 can transcriptionally activate autophagy-related genes and has
      been shown to interact
      with ATG7 in the cytoplasm, autophagy regulation is a downstream consequence
      of FOXO1's stress
      response program rather than its primary evolved function. FOXO1's core role
      is metabolic
      regulation; autophagy induction is one of many pleiotropic effects. The direct
      cytosolic
      ATG7 interaction (PMID:20543840) represents a non-canonical mechanism.
    supported_by:
    - reference_id: PMID:20543840
      supporting_text: "Cytosolic FoxO1 is essential for the induction of autophagy"

- term:
    id: GO:0006915
    label: apoptotic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >
      FOXO1 can promote apoptosis by transcriptionally activating pro-apoptotic
      genes (FASLG, BIM/BCL2L11,
      NOXA). This is a consequence of its stress-responsive transcription factor
      activity.
    action: KEEP_AS_NON_CORE
    reason: >
      FOXO1 does regulate apoptosis through transcription of pro-apoptotic genes,
      particularly under
      stress conditions. However, this is a downstream pleiotropic effect rather
      than the core evolved
      function (gluconeogenesis/metabolic regulation). Valid but non-core.
    supported_by:
    - reference_id: PMID:31063815
      supporting_text: "Moreover, CyPA induced FoxO1-dependent expression of downstream
        genes involved in EC chemotaxis and apoptosis, including monocyte chemoattractant
        protein-1 and BCL-2-interacting mediator of cell death, and stimulated the
        apoptosis of human umbilical vein ECs in vitro."

- term:
    id: GO:0008013
    label: beta-catenin binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: >
      FOXO1 interacts with beta-catenin. This interaction has functional consequences
      for FOXO1-dependent
      transcription and may relieve autoinhibition of the DNA-binding domain.
    action: ACCEPT
    reason: >
      Beta-catenin binding is documented and functionally relevant. IDA evidence
      also exists for this
      interaction (PMID:15905404).
    supported_by:
    - reference_id: PMID:15905404
      supporting_text: "Functional interaction between beta-catenin and FOXO in oxidative
        stress signaling"
    - reference_id: PMID:37710009
      supporting_text: "β-catenin can relieve autoinhibition of the DBD"

      full_text_unavailable: true
- term:
    id: GO:0030154
    label: cell differentiation
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >
      FOXO1 influences various differentiation processes including adipogenesis
      (negative regulation),
      myogenesis, and osteoblast differentiation. This is a broad pleiotropic effect
      rather than
      a specific core function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >
      "Cell differentiation" is too broad and vague. While FOXO1 does influence
      differentiation in
      multiple cell types, this is a downstream consequence of its transcriptional
      regulatory function
      rather than a core evolved function. More specific annotations (e.g., negative
      regulation of
      fat cell differentiation) are preferable.

- term:
    id: GO:0043565
    label: sequence-specific DNA binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >
      FOXO1 binds DNA in a sequence-specific manner, recognizing IRE and DBE consensus
      sequences.
    action: ACCEPT
    reason: >
      Core molecular function - sequence-specific DNA binding is fundamental to
      FOXO1's transcription
      factor activity.

# ====================
# IPI ANNOTATIONS - protein binding (require assessment of functional relevance)
# ====================
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:11237865
  review:
    summary: >
      This reference documents FOXO1 interaction with 14-3-3 proteins (YWHAG, YWHAZ).
      This is a functionally
      important interaction that mediates nuclear export after AKT phosphorylation.
    action: MODIFY
    reason: >
      While FOXO1 does bind proteins, "protein binding" is uninformative. The 14-3-3
      interaction is
      functionally critical but should be annotated to a more specific term if available
      (e.g.,
      14-3-3 protein binding or phosphoserine/phosphothreonine binding protein interaction).
    proposed_replacement_terms:
    - id: GO:0071889
      label: 14-3-3 protein binding
    supported_by:
    - reference_id: PMID:11237865
      supporting_text: "Thr-24 phosphorylation alone is critical for interaction with
        14-3-3 proteins"

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:11353774
  review:
    summary: >
      Reference describes FOXO1 functioning as a nuclear receptor coactivator/corepressor.
    action: MODIFY
    reason: >
      "Protein binding" is uninformative. The interaction with nuclear receptors
      could be more
      specifically annotated as nuclear receptor coactivator activity or similar.
    proposed_replacement_terms:
    - id: GO:0030374
      label: nuclear receptor transcription coactivator activity

    supported_by:
    - reference_id: PMID:11353774
      supporting_text: 2001 May 15. Forkhead homologue in rhabdomyosarcoma 
        functions as a bifunctional nuclear receptor-interacting protein with 
        both coactivator and corepressor functions.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:15084259
  review:
    summary: >
      Reference describes integration of Smad and forkhead pathways - FOXO1 interacts
      with Smad proteins.
    action: MODIFY
    reason: >
      Smad binding would be more informative than generic protein binding.
    proposed_replacement_terms:
    - id: GO:0070412
      label: R-SMAD binding

    supported_by:
    - reference_id: PMID:15084259
      supporting_text: Integration of Smad and forkhead pathways in the control 
        of neuroepithelial and glioblastoma cell proliferation.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:15220471
  review:
    summary: >
      Reference documents FOXO1 interaction with SIRT1. SIRT1 deacetylates FOXO1
      and potentiates its
      transcriptional activity.
    action: MODIFY
    reason: >
      The SIRT1 interaction is functionally important. A more specific term would
      be informative.
    proposed_replacement_terms:
    - id: GO:0042802
      label: identical protein binding
    supported_by:
    - reference_id: PMID:15220471
      supporting_text: "Silent information regulator 2 potentiates Foxo1-mediated
        transcription through its deacetylase activity"

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:15692560
  review:
    summary: >
      Reference describes FOXO1 interaction with FHL2 and SIRT1-mediated deacetylation.
    action: MODIFY
    reason: >
      Generic protein binding annotation should be made more specific.
    proposed_replacement_terms:
    - id: GO:0042802
      label: identical protein binding

    supported_by:
    - reference_id: PMID:15692560
      supporting_text: Suppression of FOXO1 activity by FHL2 through 
        SIRT1-mediated deacetylation.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:18235501
  review:
    summary: >
      Reference documents DBC1 as a negative regulator of SIRT1, affecting FOXO1
      indirectly.
    action: ACCEPT
    reason: >
      The interaction data is valid even if the generic term is uninformative.

    supported_by:
    - reference_id: PMID:18235501
      supporting_text: DBC1 is a negative regulator of SIRT1.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:18408765
  review:
    summary: >
      Reference describes CDK1 phosphorylation and inhibition of FOXO1.
    action: MODIFY
    reason: >
      Could be more specifically annotated as kinase binding or protein serine/threonine
      kinase activity.
    proposed_replacement_terms:
    - id: GO:0030332
      label: cyclin binding

    supported_by:
    - reference_id: PMID:18408765
      supporting_text: CDK1 promotes cell proliferation and survival via 
        phosphorylation and inhibition of FOXO1 transcription factor.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:18786403
  review:
    summary: >
      Reference is the structural study of FOXO1 DNA binding domain and its regulation
      by PTMs.
    action: ACCEPT
    reason: >
      Valid protein binding evidence from structural study.

    supported_by:
    - reference_id: PMID:18786403
      supporting_text: Structural basis for DNA recognition by FoxO1 and its 
        regulation by posttranslational modification.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:24419615
  review:
    summary: >
      Reference describes crystallization of FOXO1/ETS1 DNA-binding complex.
    action: ACCEPT
    reason: >
      Valid protein-protein interaction evidence.

    supported_by:
    - reference_id: PMID:24419615
      supporting_text: Crystallization and preliminary X-ray analysis of a 
        complex of the FOXO1 and Ets1 DNA-binding domains and DNA.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:24983498
  review:
    summary: >
      Reference describes FOXO1 interaction with SET/TAF-Ibeta (INHAT subunit).
    action: ACCEPT
    reason: >
      Valid interaction data.

    supported_by:
    - reference_id: PMID:24983498
      supporting_text: Epub 2014 Jun 28. Inhibition of FoxO1 acetylation by 
        INHAT subunit SET/TAF-Iβ induces p21 transcription.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25241761
  review:
    summary: >
      Large-scale proximity ligation assay study of protein-protein interactions.
    action: ACCEPT
    reason: >
      High-throughput interaction data, acceptable as supporting evidence.

    supported_by:
    - reference_id: PMID:25241761
      supporting_text: Oct 9. Using an in situ proximity ligation assay to 
        systematically profile endogenous protein-protein interactions in a 
        pathway network.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25609649
  review:
    summary: >
      Proteomic study of chromatin-associated transcription factor complexes.
    action: ACCEPT
    reason: >
      Valid high-throughput interaction data.

    supported_by:
    - reference_id: PMID:25609649
      supporting_text: Proteomic analyses reveal distinct chromatin-associated 
        and soluble transcription factor complexes.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:28514442
  review:
    summary: >
      Large-scale human interactome mapping study.
    action: ACCEPT
    reason: >
      Valid high-throughput interaction data.

    supported_by:
    - reference_id: PMID:28514442
      supporting_text: Architecture of the human interactome defines protein 
        communities and disease networks.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  review:
    summary: >
      Dual proteome-scale network study of human interactome.
    action: ACCEPT
    reason: >
      Valid high-throughput interaction data.

    supported_by:
    - reference_id: PMID:33961781
      supporting_text: 2021 May 6. Dual proteome-scale networks reveal 
        cell-specific remodeling of the human interactome.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:35271311
  review:
    summary: >
      OpenCell study using endogenous tagging for cellular organization mapping.
    action: ACCEPT
    reason: >
      Valid high-throughput interaction and localization data.

    supported_by:
    - reference_id: PMID:35271311
      supporting_text: '2022 Mar 11. OpenCell: Endogenous tagging for the cartography
        of human cellular organization.'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:35512704
  review:
    summary: >
      Study of mutation-directed neo-protein-protein interactions in cancer.
    action: ACCEPT
    reason: >
      Valid interaction data.

    supported_by:
    - reference_id: PMID:35512704
      supporting_text: 2022 May 4. Systematic discovery of mutation-directed 
        neo-protein-protein interactions in cancer.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:36931259
  review:
    summary: >
      Study describing 14-3-3 proteins as central chaperones with FOXO1 as a client.
    action: MODIFY
    reason: >
      This specifically documents 14-3-3 binding which should be annotated more
      specifically.
    proposed_replacement_terms:
    - id: GO:0071889
      label: 14-3-3 protein binding

# ====================
# IEA (Ensembl Compara) ANNOTATIONS
# ====================
    supported_by:
    - reference_id: PMID:36931259
      supporting_text: A central chaperone-like role for 14-3-3 proteins in 
        human cells.
- term:
    id: GO:0000785
    label: chromatin
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      FOXO1 associates with chromatin when functioning as a transcription factor.
      Recent evidence
      suggests FOXOs can act as pioneer factors to open condensed chromatin.
    action: ACCEPT
    reason: >
      FOXO1 binds to chromatin at target gene promoters. This is consistent with
      its transcription
      factor function.
    supported_by:
    - reference_id: PMID:37710009
      supporting_text: "FOXO family members can act as pioneer factors to open condensed
        chromatin"

      full_text_unavailable: true
- term:
    id: GO:0000978
    label: RNA polymerase II cis-regulatory region sequence-specific DNA binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      Duplicate of IBA annotation. FOXO1 binds to specific cis-regulatory sequences.
    action: ACCEPT
    reason: >
      Core molecular function annotation.

- term:
    id: GO:0001227
    label: DNA-binding transcription repressor activity, RNA polymerase 
      II-specific
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      FOXO1 can function as a transcriptional repressor for certain genes (e.g.,
      PDX1, PPARG).
    action: ACCEPT
    reason: >
      Valid molecular function - FOXO1 has documented repressor activity for specific
      target genes.
    supported_by:
    - reference_id: UniProt:Q12778
      supporting_text: "Acts as an inhibitor of glucose sensing in pancreatic beta
        cells by acting as a transcription repressor and suppressing expression of
        PDX1 (By similarity)."

- term:
    id: GO:0001228
    label: DNA-binding transcription activator activity, RNA polymerase 
      II-specific
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      FOXO1's primary function is as a transcriptional activator of target genes
      involved in
      metabolism, stress responses, and cell cycle regulation; its gluconeogenic
      role is supported
      in context, with an indirect FOXO1–PGC-1alpha interaction reported.
    action: ACCEPT
    reason: >
      Core molecular function - FOXO1 is primarily a transcriptional activator.
    supported_by:
    - reference_id: PMID:17024043
      supporting_text: "FOXO1 and the transcriptional co-activator PGC-1alpha act
        synergistically to stimulate the expression of genes in the gluconeogenesis
        pathway"

- term:
    id: GO:0006357
    label: regulation of transcription by RNA polymerase II
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      Duplicate annotation. FOXO1 regulates Pol II-mediated transcription.
    action: ACCEPT
    reason: >
      Core biological process for a transcription factor.

- term:
    id: GO:0006974
    label: DNA damage response
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      FOXO1 participates in DNA damage response by activating genes involved in
      DNA repair and
      cell cycle arrest. This is part of its broader stress response function.
    action: KEEP_AS_NON_CORE
    reason: >
      FOXO1 does contribute to DNA damage response through transcriptional regulation
      of relevant
      genes, but this is a downstream effect of its stress-responsive transcription
      factor activity
      rather than its primary evolved function (gluconeogenesis).
    supported_by:
    - reference_id: PMID:37891184
      supporting_text: "FOXO1 activates genes involved in DNA repair and stress resistance"

      full_text_unavailable: true
- term:
    id: GO:0008286
    label: insulin receptor signaling pathway
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      Duplicate of IBA annotation. FOXO1 is a key component of insulin signaling.
    action: ACCEPT
    reason: >
      Core biological process - FOXO1 is the main transcriptional target of insulin-PI3K-AKT
      signaling.

- term:
    id: GO:0031490
    label: chromatin DNA binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      FOXO1 binds to DNA within chromatin context at target gene promoters and enhancers.
    action: ACCEPT
    reason: >
      Specific subtype of DNA binding that accurately describes how FOXO1 functions
      in the cell.

- term:
    id: GO:0032869
    label: cellular response to insulin stimulus
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      FOXO1 mediates cellular responses to insulin - it is phosphorylated and inactivated
      by the
      insulin-stimulated PI3K-AKT pathway.
    action: ACCEPT
    reason: >
      Core function - FOXO1's regulation by insulin is central to its role in metabolic
      homeostasis.
    supported_by:
    - reference_id: PMID:10358076
      supporting_text: "Insulin disrupts IRS-dependent transactivation by FKHR"

- term:
    id: GO:0034599
    label: cellular response to oxidative stress
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      FOXO1 is activated by and mediates cellular responses to oxidative stress.
      Oxidative stress
      promotes FOXO1 nuclear localization and transcriptional activation of antioxidant
      genes.
    action: ACCEPT
    reason: >
      Core function - oxidative stress response is one of FOXO1's primary evolved
      roles alongside
      metabolic regulation. FOXOs are described as "mediators of stress adaptation."
    supported_by:
    - reference_id: PMID:37710009
      supporting_text: "FOXO transcription factors as mediators of stress adaptation"

- term:
    id: GO:0045599
    label: negative regulation of fat cell differentiation
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      FOXO1 inhibits adipogenesis by repressing PPARG expression. This is a documented
      function
      in adipocyte biology.
    action: KEEP_AS_NON_CORE
    reason: >
      Valid annotation with experimental support. FOXO1 does negatively regulate
      adipogenesis,
      but this is a tissue-specific function rather than the core evolved function
      (gluconeogenesis
      in liver). Mark as non-core.
    supported_by:
    - reference_id: UniProt:Q12778
      supporting_text: "Regulates the expression of adipogenic genes such as PPARG
        during preadipocyte differentiation"

- term:
    id: GO:0045722
    label: positive regulation of gluconeogenesis
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      Duplicate of IBA annotation. Core function of FOXO1.
    action: ACCEPT
    reason: >
      Core function - regulation of gluconeogenesis is FOXO1's primary evolved metabolic
      role.

- term:
    id: GO:0045944
    label: positive regulation of transcription by RNA polymerase II
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      FOXO1 activates transcription of target genes. This is its primary molecular
      activity.
    action: ACCEPT
    reason: >
      Core biological process - FOXO1 is primarily a transcriptional activator.

- term:
    id: GO:0046676
    label: negative regulation of insulin secretion
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      FOXO1 can negatively regulate insulin secretion in pancreatic beta cells through
      suppression of PDX1 expression.
    action: KEEP_AS_NON_CORE
    reason: >
      This is a tissue-specific function in beta cells, not the core evolved function.
      Valid but non-core.
    supported_by:
    - reference_id: UniProt:Q12778
      supporting_text: "Acts as an inhibitor of glucose sensing in pancreatic beta
        cells"

- term:
    id: GO:0051721
    label: protein phosphatase 2A binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      FOXO1 interacts with PP2A (via PPP2R1A subunit). PP2A dephosphorylates FOXO1
      at T24 and S256,
      promoting nuclear import.
    action: ACCEPT
    reason: >
      Valid molecular function - PP2A interaction is important for FOXO1 regulation.
    supported_by:
    - reference_id: UniProt:Q12778
      supporting_text: "Interacts with RUNX2; the interaction inhibits RUNX2 transcriptional
        activity and mediates the IGF1/insulin- dependent BGLAP expression in osteoblasts
        Interacts with PPP2R1A; the interaction regulates the dephosphorylation of
        FOXO1 at Thr-24 and Ser- 256 leading to its nuclear import"

- term:
    id: GO:0070542
    label: response to fatty acid
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      FOXO1 responds to fatty acids and regulates lipid metabolism genes. In chondrogenic
      commitment, FOXO1 responds to low lipid levels.
    action: KEEP_AS_NON_CORE
    reason: >
      Valid but represents a context-specific response rather than core function.
      FOXO1's role
      in lipid sensing is secondary to its primary metabolic function in gluconeogenesis.
    supported_by:
    - reference_id: UniProt:Q12778
      supporting_text: "key regulator of chondrogenic commitment of skeletal progenitor
        cells in response to lipid availability"

- term:
    id: GO:0071732
    label: cellular response to nitric oxide
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      FOXO1 mediates cellular responses to nitric oxide, including transcriptional
      activation
      of DNA repair genes in beta cells.
    action: KEEP_AS_NON_CORE
    reason: >
      Valid stress response function but represents one of many stress stimuli that
      activate FOXO1
      rather than a core evolved function.
    supported_by:
    - reference_id: UniProt:Q12778
      supporting_text: "Regulates the transcriptional activity of GADD45A and repair
        of nitric oxide-damaged DNA in beta-cells"

- term:
    id: GO:1990841
    label: promoter-specific chromatin binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >
      FOXO1 binds to chromatin at specific promoters of target genes.
    action: ACCEPT
    reason: >
      Accurate molecular function describing how FOXO1 engages chromatin at target
      gene promoters.

# ====================
# IDA (Direct assay) ANNOTATIONS - highest confidence
# ====================
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  review:
    summary: >
      Immunofluorescence data showing FOXO1 in nucleoplasm.
    action: ACCEPT
    reason: >
      Direct experimental evidence for nucleoplasm localization.

- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  review:
    summary: >
      Immunofluorescence data showing FOXO1 in cytosol.
    action: ACCEPT
    reason: >
      Direct experimental evidence. Cytosolic localization is the inactive, phosphorylated
      state.

- term:
    id: GO:0001228
    label: DNA-binding transcription activator activity, RNA polymerase 
      II-specific
  evidence_type: IDA
  original_reference_id: PMID:28851713
  review:
    summary: >
      SCP4 dephosphorylates FOXO1, promoting gluconeogenesis. This demonstrates
      FOXO1's
      transcriptional activator function.
    action: ACCEPT
    reason: >
      Core molecular function with direct experimental evidence.

    supported_by:
    - reference_id: PMID:28851713
      supporting_text: SCP4 Promotes Gluconeogenesis Through FoxO1/3a 
        Dephosphorylation.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:28851713
  review:
    summary: >
      FOXO1 interaction with SCP4 phosphatase.
    action: ACCEPT
    reason: >
      Valid protein-protein interaction.

    supported_by:
    - reference_id: PMID:28851713
      supporting_text: SCP4 Promotes Gluconeogenesis Through FoxO1/3a 
        Dephosphorylation.
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IDA
  original_reference_id: PMID:28851713
  review:
    summary: >
      Direct assay showing nuclear localization.
    action: ACCEPT
    reason: >
      Direct experimental evidence for nuclear localization.

    supported_by:
    - reference_id: PMID:28851713
      supporting_text: SCP4 Promotes Gluconeogenesis Through FoxO1/3a 
        Dephosphorylation.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:19483080
  review:
    summary: >
      FOXO1 interaction with STUB1/CHIP E3 ligase.
    action: MODIFY
    reason: >
      Could be more specifically annotated as ubiquitin ligase binding.
    proposed_replacement_terms:
    - id: GO:0031625
      label: ubiquitin protein ligase binding

    supported_by:
    - reference_id: PMID:19483080
      supporting_text: 2009 May 29. C terminus of Hsc70-interacting protein 
        promotes smooth muscle cell proliferation and survival through 
        ubiquitin-mediated degradation of FoxO1.
- term:
    id: GO:0034393
    label: positive regulation of smooth muscle cell apoptotic process
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >
      FOXO1 promotes apoptosis in smooth muscle cells through transcriptional activation
      of
      pro-apoptotic genes.
    action: KEEP_AS_NON_CORE
    reason: >
      Tissue-specific function. FOXO1 can promote apoptosis but this is a downstream
      effect
      rather than core function. Valid but non-core.
    supported_by:
    - reference_id: PMID:19483080
      supporting_text: "overexpression of CHIP repressed FoxO1-mediated transactivation
        and its proapoptotic function following tumor necrosis factor-alpha treatment."

- term:
    id: GO:0060260
    label: regulation of transcription initiation by RNA polymerase II
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >
      FOXO1 regulates transcription initiation at target gene promoters.
    action: ACCEPT
    reason: >
      Appropriate biological process term for a transcription factor.

# ====================
# TAS (Traceable Author Statement) - Reactome ANNOTATIONS
# ====================
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5692779
  review:
    summary: >
      MAPKAPK5 phosphorylates FOXO1 in nucleoplasm.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway annotation.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5692785
  review:
    summary: >
      Phosphorylated FOXO1 binds RAG gene in nucleoplasm.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway annotation.

- term:
    id: GO:0001228
    label: DNA-binding transcription activator activity, RNA polymerase 
      II-specific
  evidence_type: IDA
  original_reference_id: PMID:17024043
  review:
    summary: >
      PMID:17024043 is a comment re-evaluating the FOXO1–PGC-1alpha model and does
      not provide
      direct experimental evidence for FOXO1 transcriptional activation.
    action: MARK_AS_OVER_ANNOTATED
    reason: >
      The abstract reports FOXO1 is neither required nor sufficient for PGC-1alpha-driven
      G6Pase
      reporter activation and that the FOXO1–PGC-1alpha interaction is indirect,
      so this PMID
      alone is not strong IDA support for transcription activator activity.
    supported_by:
    - reference_id: PMID:17024043
      supporting_text: "FOXO1 is neither required nor sufficient for the stimulation
        of G6Pase-luciferase fusion gene expression by PGC-1alpha"

- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IDA
  original_reference_id: PMID:25009184
  review:
    summary: >
      p53 and SIRT6 cooperate to regulate FOXO1 nuclear localization and gluconeogenesis.
    action: ACCEPT
    reason: >
      Direct experimental evidence for nuclear localization.

    supported_by:
    - reference_id: PMID:25009184
      supporting_text: Tumor suppressor p53 cooperates with SIRT6 to regulate 
        gluconeogenesis by promoting FoxO1 nuclear exclusion.
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:25009184
  review:
    summary: >
      SIRT6-mediated deacetylation promotes FOXO1 cytoplasmic translocation.
    action: ACCEPT
    reason: >
      Direct experimental evidence showing cytoplasmic localization after SIRT6
      deacetylation.
    supported_by:
    - reference_id: PMID:25009184
      supporting_text: "whose interaction with FoxO1 leads to FoxO1 deacetylation
        and export to the cytoplasm."

- term:
    id: GO:0045722
    label: positive regulation of gluconeogenesis
  evidence_type: IDA
  original_reference_id: PMID:17024043
  review:
    summary: >
      PMID:17024043 re-evaluates the FOXO1–PGC-1alpha connection and reports FOXO1
      is not required
      or sufficient for PGC-1alpha-driven G6Pase reporter activation.
    action: MARK_AS_OVER_ANNOTATED
    reason: >
      This comment does not provide direct evidence that FOXO1 positively regulates
      gluconeogenesis;
      it instead reports an indirect FOXO1–PGC-1alpha interaction and lack of requirement
      for FOXO1
      in PGC-1alpha-driven G6Pase reporter activity.
    supported_by:
    - reference_id: PMID:17024043
      supporting_text: "FOXO1 is neither required nor sufficient for the stimulation
        of G6Pase-luciferase fusion gene expression by PGC-1alpha"

- term:
    id: GO:0045722
    label: positive regulation of gluconeogenesis
  evidence_type: IDA
  original_reference_id: PMID:25009184
  review:
    summary: >
      SIRT6 inhibits FOXO1-mediated gluconeogenesis by promoting nuclear exclusion.
    action: ACCEPT
    reason: >
      Additional evidence for FOXO1's core gluconeogenic function.

    supported_by:
    - reference_id: PMID:25009184
      supporting_text: Tumor suppressor p53 cooperates with SIRT6 to regulate 
        gluconeogenesis by promoting FoxO1 nuclear exclusion.
- term:
    id: GO:0046676
    label: negative regulation of insulin secretion
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >
      FOXO1 inhibits insulin secretion in beta cells.
    action: KEEP_AS_NON_CORE
    reason: >
      Tissue-specific function in pancreatic beta cells, not core evolved function.

- term:
    id: GO:0003676
    label: nucleic acid binding
  evidence_type: EXP
  original_reference_id: PMID:18786403
  review:
    summary: >
      Structural study demonstrating FOXO1's DNA binding activity.
    action: ACCEPT
    reason: >
      General term but supported by structural evidence. More specific terms also
      present.

    supported_by:
    - reference_id: PMID:18786403
      supporting_text: Structural basis for DNA recognition by FoxO1 and its 
        regulation by posttranslational modification.
- term:
    id: GO:0003700
    label: DNA-binding transcription factor activity
  evidence_type: IDA
  original_reference_id: PMID:17024043
  review:
    summary: >
      PMID:17024043 discusses FOXO1 in the context of gluconeogenic gene regulation
      but provides
      limited direct evidence for transcription factor activity.
    action: MARK_AS_OVER_ANNOTATED
    reason: >
      This comment focuses on re-evaluating the FOXO1–PGC-1alpha relationship and
      reports an
      indirect interaction; it is not primary experimental evidence of FOXO1 transcription
      factor
      activity.

    supported_by:
    - reference_id: PMID:17024043
      supporting_text: 'Gluconeogenesis: re-evaluating the FOXO1-PGC-1alpha connection.'
- term:
    id: GO:0003700
    label: DNA-binding transcription factor activity
  evidence_type: IMP
  original_reference_id: PMID:31063815
  review:
    summary: >
      Cyclophilin A-FOXO1 signaling in endothelial cell apoptosis demonstrates FOXO1's
      transcription factor activity.
    action: ACCEPT
    reason: >
      Mutant phenotype evidence for transcription factor function.

    supported_by:
    - reference_id: PMID:31063815
      supporting_text: May 4. Cyclophilin A-FoxO1 signaling pathway in 
        endothelial cell apoptosis.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:31063815
  review:
    summary: >
      FOXO1 interacts with cyclophilin A (PPIA).
    action: ACCEPT
    reason: >
      Valid protein-protein interaction.

    supported_by:
    - reference_id: PMID:31063815
      supporting_text: May 4. Cyclophilin A-FoxO1 signaling pathway in 
        endothelial cell apoptosis.
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IDA
  original_reference_id: PMID:31063815
  review:
    summary: >
      Nuclear localization demonstrated in endothelial cell study.
    action: ACCEPT
    reason: >
      Direct experimental evidence.

    supported_by:
    - reference_id: PMID:31063815
      supporting_text: May 4. Cyclophilin A-FoxO1 signaling pathway in 
        endothelial cell apoptosis.
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:31063815
  review:
    summary: >
      Cytoplasmic localization in endothelial cells.
    action: ACCEPT
    reason: >
      Direct experimental evidence.

    supported_by:
    - reference_id: PMID:31063815
      supporting_text: May 4. Cyclophilin A-FoxO1 signaling pathway in 
        endothelial cell apoptosis.
- term:
    id: GO:0006915
    label: apoptotic process
  evidence_type: IMP
  original_reference_id: PMID:31063815
  review:
    summary: >
      FOXO1 regulates endothelial cell apoptosis through transcription of BCL2L11.
    action: KEEP_AS_NON_CORE
    reason: >
      Valid annotation showing FOXO1's role in apoptosis, but this is a downstream
      effect
      of transcriptional regulation rather than core function.
    supported_by:
    - reference_id: PMID:31063815
      supporting_text: "Moreover, CyPA induced FoxO1-dependent expression of downstream
        genes involved in EC chemotaxis and apoptosis, including monocyte chemoattractant
        protein-1 and BCL-2-interacting mediator of cell death, and stimulated the
        apoptosis of human umbilical vein ECs in vitro."

- term:
    id: GO:0001228
    label: DNA-binding transcription activator activity, RNA polymerase 
      II-specific
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >
      Sequence similarity-based evidence for transcriptional activator function.
    action: ACCEPT
    reason: >
      Core function supported by multiple evidence types.

- term:
    id: GO:0070542
    label: response to fatty acid
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >
      FOXO1 responds to fatty acid levels.
    action: KEEP_AS_NON_CORE
    reason: >
      Context-specific response, not core function.

- term:
    id: GO:0000785
    label: chromatin
  evidence_type: ISA
  original_reference_id: GO_REF:0000113
  review:
    summary: >
      TFClass database annotation for chromatin association.
    action: ACCEPT
    reason: >
      Valid cellular component annotation.

- term:
    id: GO:0000981
    label: DNA-binding transcription factor activity, RNA polymerase II-specific
  evidence_type: ISA
  original_reference_id: GO_REF:0000113
  review:
    summary: >
      TFClass database annotation for Pol II transcription factor activity.
    action: ACCEPT
    reason: >
      Core molecular function.

- term:
    id: GO:1903243
    label: negative regulation of cardiac muscle hypertrophy in response to 
      stress
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >
      FOXO1 can inhibit cardiac hypertrophy.
    action: KEEP_AS_NON_CORE
    reason: >
      Tissue-specific function in heart. Valid but not core function.
    supported_by:
    - reference_id: UniProt:Q12778
      supporting_text: "Mediates the function of MLIP in cardiomyocytes hypertrophy
        and cardiac remodeling"

- term:
    id: GO:0045944
    label: positive regulation of transcription by RNA polymerase II
  evidence_type: IMP
  original_reference_id: PMID:27577745
  review:
    summary: >
      MARCH1 study showing FOXO1's transcriptional activation function.
    action: ACCEPT
    reason: >
      Core biological process.

    supported_by:
    - reference_id: PMID:27577745
      supporting_text: MARCH1 regulates insulin sensitivity by controlling cell 
        surface insulin receptor levels.
- term:
    id: GO:0008013
    label: beta-catenin binding
  evidence_type: IDA
  original_reference_id: PMID:15905404
  review:
    summary: >
      Direct evidence for FOXO1-beta-catenin interaction in oxidative stress signaling.
    action: ACCEPT
    reason: >
      Direct experimental evidence for specific protein-protein interaction.
    supported_by:
    - reference_id: PMID:15905404
      supporting_text: "Functional interaction between beta-catenin and FOXO in oxidative
        stress signaling"

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:20543840
  review:
    summary: >
      FOXO1 interacts with ATG7 in cytoplasm for autophagy induction.
    action: ACCEPT
    reason: >
      Valid protein-protein interaction data.

    supported_by:
    - reference_id: PMID:20543840
      supporting_text: Cytosolic FoxO1 is essential for the induction of 
        autophagy and tumour suppressor activity.
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IDA
  original_reference_id: PMID:20543840
  review:
    summary: >
      Nuclear localization in autophagy study.
    action: ACCEPT
    reason: >
      Direct experimental evidence.

    supported_by:
    - reference_id: PMID:20543840
      supporting_text: Cytosolic FoxO1 is essential for the induction of 
        autophagy and tumour suppressor activity.
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:20543840
  review:
    summary: >
      Cytoplasmic localization important for autophagy function.
    action: ACCEPT
    reason: >
      Direct experimental evidence.

    supported_by:
    - reference_id: PMID:20543840
      supporting_text: Cytosolic FoxO1 is essential for the induction of 
        autophagy and tumour suppressor activity.
- term:
    id: GO:0009267
    label: cellular response to starvation
  evidence_type: IDA
  original_reference_id: PMID:20543840
  review:
    summary: >
      FOXO1 mediates cellular response to starvation/nutrient deprivation.
    action: ACCEPT
    reason: >
      Core function - FOXO1 is activated by starvation to promote gluconeogenesis
      and autophagy.
    supported_by:
    - reference_id: PMID:20543840
      supporting_text: "Endogenous FoxO1 was required for autophagy in human cancer
        cell lines in response to oxidative stress or serum starvation, but this process
        was independent of the transcriptional activity of FoxO1."

- term:
    id: GO:0010508
    label: positive regulation of autophagy
  evidence_type: IMP
  original_reference_id: PMID:20543840
  review:
    summary: >
      FOXO1 promotes autophagy through both transcriptional and non-transcriptional
      mechanisms.
    action: KEEP_AS_NON_CORE
    reason: >
      Valid but represents a downstream stress response rather than core function.
      The core
      function is metabolic regulation.
    supported_by:
    - reference_id: PMID:20543840
      supporting_text: "Cytosolic FoxO1 is essential for the induction of autophagy"

- term:
    id: GO:0031625
    label: ubiquitin protein ligase binding
  evidence_type: IPI
  original_reference_id: PMID:20543840
  review:
    summary: >
      FOXO1 interacts with ubiquitin E3 ligases including STUB1/CHIP.
    action: ACCEPT
    reason: >
      Valid molecular function relevant to FOXO1 regulation.

    supported_by:
    - reference_id: PMID:20543840
      supporting_text: Cytosolic FoxO1 is essential for the induction of 
        autophagy and tumour suppressor activity.
- term:
    id: GO:0043065
    label: positive regulation of apoptotic process
  evidence_type: IMP
  original_reference_id: PMID:20543840
  review:
    summary: >
      FOXO1 promotes apoptosis under stress conditions.
    action: KEEP_AS_NON_CORE
    reason: >
      Valid but downstream effect of FOXO1's transcriptional activity rather than
      core function.
    supported_by:
    - reference_id: PMID:20543840
      supporting_text: "Cytosolic FoxO1 is essential for the induction of autophagy
        and tumour suppressor activity."

- term:
    id: GO:0045732
    label: positive regulation of protein catabolic process
  evidence_type: IMP
  original_reference_id: PMID:20543840
  review:
    summary: >
      FOXO1 promotes protein catabolism through autophagy induction.
    action: KEEP_AS_NON_CORE
    reason: >
      Downstream effect of autophagy induction, not core function.

    supported_by:
    - reference_id: PMID:20543840
      supporting_text: Cytosolic FoxO1 is essential for the induction of 
        autophagy and tumour suppressor activity.
- term:
    id: GO:0071455
    label: cellular response to hyperoxia
  evidence_type: IDA
  original_reference_id: PMID:20543840
  review:
    summary: >
      FOXO1 responds to oxidative stress including hyperoxia.
    action: ACCEPT
    reason: >
      Part of FOXO1's stress response function.

    supported_by:
    - reference_id: PMID:20543840
      supporting_text: Cytosolic FoxO1 is essential for the induction of 
        autophagy and tumour suppressor activity.
- term:
    id: GO:0032869
    label: cellular response to insulin stimulus
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >
      Duplicate annotation for insulin response.
    action: ACCEPT
    reason: >
      Core function.

- term:
    id: GO:0045599
    label: negative regulation of fat cell differentiation
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >
      FOXO1 inhibits adipogenesis.
    action: KEEP_AS_NON_CORE
    reason: >
      Tissue-specific function, not core.

- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-211178
  review:
    summary: >
      Phosphorylated FOXO1 is excluded from nucleus and found in cytosol.
    action: ACCEPT
    reason: >
      Valid localization annotation.

- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9614414
  review:
    summary: >
      AKT-phosphorylated FOXO translocates to cytosol.
    action: ACCEPT
    reason: >
      Valid localization.

- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9614423
  review:
    summary: >
      14-3-3 binds phosphorylated FOXO1 in cytosol.
    action: ACCEPT
    reason: >
      Valid localization.

- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: ISS
  original_reference_id: PMID:22510882
  review:
    summary: >
      Some evidence for mitochondrial localization of FOXO1.
    action: UNDECIDED
    reason: >
      Mitochondrial localization of FOXO1 is not well-established. The primary localizations
      are nucleus and cytoplasm. This may represent a minor or context-specific
      localization.
      Need more evidence.

    supported_by:
    - reference_id: PMID:22510882
      supporting_text: Novel repressor regulates insulin sensitivity through 
        interaction with Foxo1.
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IDA
  original_reference_id: PMID:18680538
  review:
    summary: >
      Nuclear localization evidence.
    action: ACCEPT
    reason: >
      Direct evidence for nuclear localization.

# Multiple Reactome TAS annotations for nucleoplasm - consolidate review
    supported_by:
    - reference_id: PMID:18680538
      supporting_text: GAS6-induced signaling in human endothelial cells is 
        mediated by FOXO1a.
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-199299
  review:
    summary: >
      AKT phosphorylates FOXO transcription factors in nucleoplasm.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-211164
  review:
    summary: >
      AKT phosphorylates FOXO1A in nucleoplasm.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-211178
  review:
    summary: >
      Phosphorylated FOXO1A is excluded from the nucleus.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2399992
  review:
    summary: >
      AKT1 E17K mutant phosphorylates FOXO transcription factors.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6790036
  review:
    summary: >
      STAT3-upregulated nuclear proteins including FOXO.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9614414
  review:
    summary: >
      AKT-phosphorylated FOXOs translocate to cytosol.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9614662
  review:
    summary: >
      FOXO1 binds FASLG gene promoter.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9617840
  review:
    summary: >
      FOXO1 binds CDKN1A gene promoter.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9617996
  review:
    summary: >
      FOXO1 binds SMAD2/3:SMAD4 complex.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9622980
  review:
    summary: >
      FOXO1 binds NPY gene promoter.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9623415
  review:
    summary: >
      FOXO1 binds IGFBP1 gene promoter.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9624976
  review:
    summary: >
      FOXO1 binds CAV1 gene promoter.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9625091
  review:
    summary: >
      FOXO1 binds ABCA6 gene promoter.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9626928
  review:
    summary: >
      CREBBP binds FOXO1.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-NUL-9620806
  review:
    summary: >
      FOXO1 binds Rbl2 gene.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-NUL-9620857
  review:
    summary: >
      FOXO1 binds Ccng2 gene.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-NUL-9624599
  review:
    summary: >
      FOXO1 binds Fbxo32 gene promoter.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-NUL-9625492
  review:
    summary: >
      FOXO1 and Smad2/3:Smad4 bind Mstn gene promoter.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-NUL-9625758
  review:
    summary: >
      FOXO1 and SMAD3 bind Trim63 gene promoter.
    action: ACCEPT
    reason: >
      Supported by Reactome pathway.

- term:
    id: GO:0006974
    label: DNA damage response
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >
      FOXO1 participates in DNA damage response.
    action: KEEP_AS_NON_CORE
    reason: >
      Downstream stress response, not core function.

- term:
    id: GO:0071732
    label: cellular response to nitric oxide
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >
      FOXO1 responds to nitric oxide.
    action: KEEP_AS_NON_CORE
    reason: >
      Stress response, not core function.

- term:
    id: GO:0034599
    label: cellular response to oxidative stress
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >
      FOXO1 responds to oxidative stress.
    action: ACCEPT
    reason: >
      Core function - oxidative stress response is one of FOXO1's primary evolved
      roles.

- term:
    id: GO:0051721
    label: protein phosphatase 2A binding
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >
      PP2A binding for FOXO1 dephosphorylation.
    action: ACCEPT
    reason: >
      Valid molecular function.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:15890677
  review:
    summary: >
      FOXO1 interacts with p300 coactivator.
    action: MODIFY
    reason: >
      Should be annotated more specifically.
    proposed_replacement_terms:
    - id: GO:0003713
      label: transcription coactivator activity

    supported_by:
    - reference_id: PMID:15890677
      supporting_text: May 12. The coactivator p300 directly acetylates the 
        forkhead transcription factor Foxo1 and stimulates Foxo1-induced 
        transcription.
- term:
    id: GO:0001659
    label: temperature homeostasis
  evidence_type: ISS
  original_reference_id: PMID:22510882
  review:
    summary: >
      FOXO1 role in temperature homeostasis through metabolic regulation.
    action: KEEP_AS_NON_CORE
    reason: >
      Downstream physiological effect, not core molecular function.

    supported_by:
    - reference_id: PMID:22510882
      supporting_text: Novel repressor regulates insulin sensitivity through 
        interaction with Foxo1.
- term:
    id: GO:0001678
    label: intracellular glucose homeostasis
  evidence_type: ISS
  original_reference_id: PMID:22510882
  review:
    summary: >
      FOXO1 regulates glucose homeostasis through gluconeogenic gene transcription.
    action: ACCEPT
    reason: >
      Core function - glucose homeostasis is central to FOXO1's evolved role.
    supported_by:
    - reference_id: PMID:37891184
      supporting_text: "hepatic FOXO1 controls gluconeogenic programs"

      full_text_unavailable: true
    - reference_id: PMID:22510882
      supporting_text: Novel repressor regulates insulin sensitivity through 
        interaction with Foxo1.
- term:
    id: GO:0003682
    label: chromatin binding
  evidence_type: ISS
  original_reference_id: PMID:22510882
  review:
    summary: >
      FOXO1 binds chromatin at target gene promoters.
    action: ACCEPT
    reason: >
      Valid molecular function for a transcription factor.

    supported_by:
    - reference_id: PMID:22510882
      supporting_text: Novel repressor regulates insulin sensitivity through 
        interaction with Foxo1.
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: ISS
  original_reference_id: PMID:22510882
  review:
    summary: >
      Cytosolic localization.
    action: ACCEPT
    reason: >
      Valid cellular component annotation.

    supported_by:
    - reference_id: PMID:22510882
      supporting_text: Novel repressor regulates insulin sensitivity through 
        interaction with Foxo1.
- term:
    id: GO:0006473
    label: protein acetylation
  evidence_type: ISS
  original_reference_id: PMID:22510882
  review:
    summary: >
      FOXO1 is acetylated; its acetylation status regulates activity.
    action: MARK_AS_OVER_ANNOTATED
    reason: >
      This term implies FOXO1 has acetyltransferase activity, which is incorrect.
      FOXO1 is
      a substrate of acetylation, not an enzyme that performs acetylation. The annotation
      should be removed or replaced with a term about being modified by acetylation.

    supported_by:
    - reference_id: PMID:22510882
      supporting_text: Novel repressor regulates insulin sensitivity through 
        interaction with Foxo1.
- term:
    id: GO:0009267
    label: cellular response to starvation
  evidence_type: ISS
  original_reference_id: PMID:22510882
  review:
    summary: >
      FOXO1 responds to starvation by promoting gluconeogenesis.
    action: ACCEPT
    reason: >
      Core function - starvation response through gluconeogenesis is central to
      FOXO1.

    supported_by:
    - reference_id: PMID:22510882
      supporting_text: Novel repressor regulates insulin sensitivity through 
        interaction with Foxo1.
- term:
    id: GO:0045444
    label: fat cell differentiation
  evidence_type: ISS
  original_reference_id: PMID:22510882
  review:
    summary: >
      FOXO1 regulates adipogenesis.
    action: KEEP_AS_NON_CORE
    reason: >
      Tissue-specific function, not core. FOXO1 inhibits rather than promotes this
      process.

    supported_by:
    - reference_id: PMID:22510882
      supporting_text: Novel repressor regulates insulin sensitivity through 
        interaction with Foxo1.
- term:
    id: GO:0045892
    label: negative regulation of DNA-templated transcription
  evidence_type: ISS
  original_reference_id: PMID:22510882
  review:
    summary: >
      FOXO1 can repress transcription of certain genes.
    action: ACCEPT
    reason: >
      Valid biological process - FOXO1 acts as repressor for some targets.

    supported_by:
    - reference_id: PMID:22510882
      supporting_text: Novel repressor regulates insulin sensitivity through 
        interaction with Foxo1.
- term:
    id: GO:0070417
    label: cellular response to cold
  evidence_type: ISS
  original_reference_id: PMID:22510882
  review:
    summary: >
      FOXO1 role in cold response through metabolic adaptation.
    action: KEEP_AS_NON_CORE
    reason: >
      Downstream physiological effect, not core molecular function.

    supported_by:
    - reference_id: PMID:22510882
      supporting_text: Novel repressor regulates insulin sensitivity through 
        interaction with Foxo1.
- term:
    id: GO:0097009
    label: energy homeostasis
  evidence_type: ISS
  original_reference_id: PMID:22510882
  review:
    summary: >
      FOXO1 regulates energy homeostasis through metabolic gene transcription.
    action: ACCEPT
    reason: >
      Core function - energy/metabolic homeostasis is central to FOXO1.

    supported_by:
    - reference_id: PMID:22510882
      supporting_text: Novel repressor regulates insulin sensitivity through 
        interaction with Foxo1.
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:11237865
  review:
    summary: >
      Cytoplasmic localization with 14-3-3 binding.
    action: ACCEPT
    reason: >
      Direct experimental evidence.

    supported_by:
    - reference_id: PMID:11237865
      supporting_text: Roles of the forkhead in rhabdomyosarcoma (FKHR) 
        phosphorylation sites in regulating 14-3-3 binding, transactivation and 
        nuclear targetting.
- term:
    id: GO:0008286
    label: insulin receptor signaling pathway
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >
      FOXO1 in insulin signaling.
    action: ACCEPT
    reason: >
      Core function.

- term:
    id: GO:0032873
    label: negative regulation of stress-activated MAPK cascade
  evidence_type: IDA
  original_reference_id: PMID:19696738
  review:
    summary: >
      FoxM1 paper - may be mislabeled for FOXO1.
    action: UNDECIDED
    reason: >
      The cited reference PMID:19696738 is about FoxM1, not FOXO1. This may be an
      annotation
      error. Need verification.

    supported_by:
    - reference_id: PMID:19696738
      supporting_text: FoxM1, a critical regulator of oxidative stress during 
        oncogenesis.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:17030088
  review:
    summary: >
      FOXO1 interacts with APPL1, APPL2, AKT2 in FSH receptor complex.
    action: ACCEPT
    reason: >
      Valid protein-protein interaction data.

    supported_by:
    - reference_id: PMID:17030088
      supporting_text: Epub 2006 Oct 9. APPL1, APPL2, Akt2 and FOXO1a interact 
        with FSHR in a potential signaling complex.
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IDA
  original_reference_id: PMID:11311120
  review:
    summary: >
      DYRK1A phosphorylation study showing nuclear FOXO1.
    action: ACCEPT
    reason: >
      Direct experimental evidence.
    supported_by:
    - reference_id: PMID:11311120
      supporting_text: "Ser(329) phosphorylation also decreases the ability of FKHR
        to stimulate gene transactivation and reduces the proportion of FKHR present
        in the nucleus."

- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IDA
  original_reference_id: PMID:12228231
  review:
    summary: >
      Phosphorylation study showing nuclear localization.
    action: ACCEPT
    reason: >
      Direct experimental evidence.

    supported_by:
    - reference_id: PMID:12228231
      supporting_text: 2002 Sep 12. Phosphorylation of serine 256 suppresses 
        transactivation by FKHR (FOXO1) by multiple mechanisms.
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:11311120
  review:
    summary: >
      Cytoplasmic localization after phosphorylation.
    action: ACCEPT
    reason: >
      Direct experimental evidence.

    supported_by:
    - reference_id: PMID:11311120
      supporting_text: The kinase DYRK1A phosphorylates the transcription factor
        FKHR at Ser329 in vitro, a novel in vivo phosphorylation site.
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:12228231
  review:
    summary: >
      Cytoplasmic localization after insulin stimulation.
    action: ACCEPT
    reason: >
      Direct experimental evidence.

    supported_by:
    - reference_id: PMID:12228231
      supporting_text: 2002 Sep 12. Phosphorylation of serine 256 suppresses 
        transactivation by FKHR (FOXO1) by multiple mechanisms.
- term:
    id: GO:0043066
    label: negative regulation of apoptotic process
  evidence_type: IDA
  original_reference_id: PMID:10871843
  review:
    summary: >
      PAX3/FKHR fusion study - shows FOXO1 can have anti-apoptotic effects in certain
      contexts.
    action: UNDECIDED
    reason: >
      This reference is about PAX3-FKHR fusion protein in rhabdomyosarcoma, not
      wild-type
      FOXO1 function. The annotation may be misleading as FOXO1 is generally pro-apoptotic.
      Need clarification.

    supported_by:
    - reference_id: PMID:10871843
      supporting_text: Transcriptional modulation of the anti-apoptotic protein 
        BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR.
- term:
    id: GO:0043565
    label: sequence-specific DNA binding
  evidence_type: IDA
  original_reference_id: PMID:12228231
  review:
    summary: >
      Direct evidence for sequence-specific DNA binding from phosphorylation study.
    action: ACCEPT
    reason: >
      Core molecular function with direct evidence.
    supported_by:
    - reference_id: PMID:12228231
      supporting_text: "Phosphorylation of serine 256 suppresses transactivation by
        FKHR (FOXO1) by multiple mechanisms."

- term:
    id: GO:0045893
    label: positive regulation of DNA-templated transcription
  evidence_type: IDA
  original_reference_id: PMID:10871843
  review:
    summary: >
      PAX3/FKHR study showing transcriptional activation.
    action: ACCEPT
    reason: >
      Direct evidence for transcriptional activation function.

    supported_by:
    - reference_id: PMID:10871843
      supporting_text: Transcriptional modulation of the anti-apoptotic protein 
        BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR.
- term:
    id: GO:0045893
    label: positive regulation of DNA-templated transcription
  evidence_type: IDA
  original_reference_id: PMID:12228231
  review:
    summary: >
      Evidence for FOXO1 transcriptional activation function.
    action: ACCEPT
    reason: >
      Core biological process.

    supported_by:
    - reference_id: PMID:12228231
      supporting_text: 2002 Sep 12. Phosphorylation of serine 256 suppresses 
        transactivation by FKHR (FOXO1) by multiple mechanisms.
- term:
    id: GO:0045893
    label: positive regulation of DNA-templated transcription
  evidence_type: IDA
  original_reference_id: PMID:7862145
  review:
    summary: >
      Early PAX3-FKHR fusion study showing transcriptional activation.
    action: ACCEPT
    reason: >
      Early evidence for FOXO1's transactivation domain function.

    supported_by:
    - reference_id: PMID:7862145
      supporting_text: The PAX3-FKHR fusion protein created by the t(2;13) 
        translocation in alveolar rhabdomyosarcomas is a more potent 
        transcriptional activator than PAX3.
- term:
    id: GO:0045944
    label: positive regulation of transcription by RNA polymerase II
  evidence_type: IDA
  original_reference_id: PMID:10871843
  review:
    summary: >
      Evidence for Pol II-mediated transcription activation.
    action: ACCEPT
    reason: >
      Core biological process.

    supported_by:
    - reference_id: PMID:10871843
      supporting_text: Transcriptional modulation of the anti-apoptotic protein 
        BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR.
- term:
    id: GO:0045944
    label: positive regulation of transcription by RNA polymerase II
  evidence_type: IDA
  original_reference_id: PMID:12228231
  review:
    summary: >
      Evidence for Pol II-mediated transcription activation.
    action: ACCEPT
    reason: >
      Core biological process.

    supported_by:
    - reference_id: PMID:12228231
      supporting_text: 2002 Sep 12. Phosphorylation of serine 256 suppresses 
        transactivation by FKHR (FOXO1) by multiple mechanisms.
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with 
    GO terms
  findings: []
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to
    orthologs by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data
    to orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000108
  title: Automatic assignment of GO terms using logical inference, based on on 
    inter-ontology links
  findings: []
- id: GO_REF:0000113
  title: Gene Ontology annotation of human sequence-specific DNA binding 
    transcription factors (DbTFs) based on the TFClass database
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning 
    models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:10358076
  title: Phosphorylation of serine 256 by protein kinase B disrupts 
    transactivation by FKHR
  findings:
  - statement: FOXO1 binds to IRE consensus sequence and is suppressed by 
      insulin-activated AKT
- id: PMID:10871843
  title: Transcriptional modulation of the anti-apoptotic protein BCL-XL by the 
    paired box transcription factors PAX3 and PAX3/FKHR.
  findings: []
- id: PMID:11237865
  title: Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites 
    in regulating 14-3-3 binding, transactivation and nuclear targetting.
  findings:
  - statement: AKT phosphorylation of T24/S256/S319 promotes 14-3-3 binding and 
      nuclear export
- id: PMID:11311120
  title: The kinase DYRK1A phosphorylates the transcription factor FKHR at 
    Ser329 in vitro, a novel in vivo phosphorylation site.
  findings:
  - statement: FOXO1 is largely nuclear in unstimulated cells
- id: PMID:11353774
  title: Forkhead homologue in rhabdomyosarcoma functions as a bifunctional 
    nuclear receptor-interacting protein with both coactivator and corepressor 
    functions.
  findings: []
- id: PMID:12228231
  title: Phosphorylation of serine 256 suppresses transactivation by FKHR
  findings:
  - statement: Ser256 phosphorylation decreases DNA binding and promotes nuclear
      exclusion
- id: PMID:15084259
  title: Integration of Smad and forkhead pathways
  findings: []
- id: PMID:15220471
  title: Silent information regulator 2 potentiates Foxo1-mediated transcription
    through its deacetylase activity.
  findings:
  - statement: SIRT1 deacetylates FOXO1 and enhances transcriptional activity
- id: PMID:15692560
  title: Suppression of FOXO1 activity by FHL2 through SIRT1-mediated 
    deacetylation
  findings: []
- id: PMID:15890677
  title: The coactivator p300 directly acetylates the forkhead transcription 
    factor Foxo1 and stimulates Foxo1-induced transcription.
  findings:
  - statement: p300/CBP acetylate FOXO1 and modulate its activity
- id: PMID:15905404
  title: Functional interaction between beta-catenin and FOXO in oxidative 
    stress signaling
  findings:
  - statement: Beta-catenin interacts with FOXO1 and modulates oxidative stress 
      response
- id: PMID:17024043
  title: "Gluconeogenesis: re-evaluating the FOXO1-PGC-1alpha connection"
  findings:
  - statement: The original model proposed FOXO1 and PGC-1alpha act 
      synergistically to stimulate gluconeogenic gene expression.
    supporting_text: "FOXO1 and the transcriptional co-activator PGC-1alpha act synergistically
      to stimulate the expression of genes in the gluconeogenesis pathway"
  - statement: This report finds FOXO1 is neither required nor sufficient for 
      PGC-1alpha-driven activation of G6Pase reporter expression.
    supporting_text: "FOXO1 is neither required nor sufficient for the stimulation
      of G6Pase-luciferase fusion gene expression by PGC-1alpha"
  - statement: The data indicate the FOXO1–PGC-1alpha transcriptional 
      interaction is indirect.
    supporting_text: "the transcriptional interaction between FOXO1 and PGC-1alpha
      is indirect"
- id: PMID:17030088
  title: APPL1, APPL2, Akt2 and FOXO1a interact with FSHR
  findings: []
- id: PMID:18235501
  title: DBC1 is a negative regulator of SIRT1
  findings: []
- id: PMID:18356527
  title: Activation of FOXO1 by Cdk1
  findings:
  - statement: CDK1 phosphorylates FOXO1 at Ser249
- id: PMID:18408765
  title: CDK1 promotes cell proliferation and survival via phosphorylation and 
    inhibition of FOXO1 transcription factor.
  findings: []
- id: PMID:18680538
  title: GAS6-induced signaling in human endothelial cells is mediated by 
    FOXO1a.
  findings: []
- id: PMID:18786403
  title: Structural basis for DNA recognition by FoxO1
  findings:
  - statement: X-ray crystallography of FOXO1 DNA-binding domain
- id: PMID:19483080
  title: C terminus of Hsc70-interacting protein promotes smooth muscle cell 
    proliferation and survival through ubiquitin-mediated degradation of FoxO1.
  findings:
  - statement: STUB1/CHIP ubiquitinates and degrades FOXO1
- id: PMID:19696738
  title: FoxM1, a critical regulator of oxidative stress during oncogenesis.
  findings: []
- id: PMID:20543840
  title: Cytosolic FoxO1 is essential for the induction of autophagy and tumour 
    suppressor activity.
  findings:
  - statement: Acetylated cytosolic FOXO1 interacts with ATG7 to promote 
      autophagy
- id: PMID:22510882
  title: Novel repressor regulates insulin sensitivity through interaction with 
    Foxo1.
  findings: []
- id: PMID:24419615
  title: Crystallization and preliminary X-ray analysis of a complex of the 
    FOXO1 and Ets1 DNA-binding domains and DNA.
  findings: []
- id: PMID:24983498
  title: Inhibition of FoxO1 acetylation by INHAT subunit SET/TAF-Iβ induces p21
    transcription.
  findings: []
- id: PMID:25009184
  title: Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis 
    by promoting FoxO1 nuclear exclusion.
  findings:
  - statement: SIRT6 deacetylates FOXO1 at K423 promoting cytoplasmic 
      translocation
- id: PMID:25241761
  title: Using an in situ proximity ligation assay to systematically profile 
    endogenous protein-protein interactions in a pathway network.
  findings: []
- id: PMID:25609649
  title: Proteomic analyses reveal distinct chromatin-associated and soluble 
    transcription factor complexes.
  findings: []
- id: PMID:27577745
  title: MARCH1 regulates insulin sensitivity by controlling cell surface 
    insulin receptor
  findings: []
- id: PMID:28514442
  title: Architecture of the human interactome
  findings: []
- id: PMID:28851713
  title: SCP4 promotes gluconeogenesis through FoxO1/3a dephosphorylation
  findings: []
- id: PMID:31063815
  title: Cyclophilin A-FoxO1 signaling pathway in endothelial cell apoptosis.
  findings:
  - statement: PPIA promotes FOXO1 dephosphorylation and nuclear accumulation
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the 
    human interactome.
  findings: []
- id: PMID:35271311
  title: 'OpenCell: Endogenous tagging for the cartography of human cellular organization.'
  findings: []
- id: PMID:35512704
  title: Systematic discovery of mutation-directed neo-protein-protein 
    interactions
  findings: []
- id: PMID:36931259
  title: A central chaperone-like role for 14-3-3 proteins in human cells.
  findings: []
- id: PMID:7862145
  title: The PAX3-FKHR fusion protein created by the t(2;13) translocation in 
    alveolar rhabdomyosarcomas is a more potent transcriptional activator than 
    PAX3.
  findings: []
- id: santos2023foxofamilyisoforms
  title: FOXO family isoforms
  findings:
  - statement: FOXO1 is a forkhead box O transcription factor with conserved 
      winged-helix DBD
  - statement: AKT phosphorylation creates 14-3-3 binding sites driving nuclear 
      export
- id: cheng2024forkheadboxo
  title: Forkhead box O proteins - steering the course of stem cell fate
  findings:
  - statement: FOXO proteins recognize DBE (5'-TTGTTTAC-3') with high affinity
- id: rodriguezcolman2024foxotranscriptionfactors
  title: FOXO transcription factors as mediators of stress adaptation
  findings:
  - statement: FOXOs can act as pioneer factors to open condensed chromatin
  - statement: PTM code determines context-specific genome engagement
- id: Reactome:R-HSA-199299
  title: AKT phosphorylates FOXO transcription factors
  findings: []
- id: Reactome:R-HSA-211164
  title: AKT phosphorylates FOXO1A
  findings: []
- id: Reactome:R-HSA-211178
  title: Phosphorylated FOXO1A is excluded from the nucleus
  findings: []
- id: Reactome:R-HSA-2399992
  title: AKT1 E17K mutant phosphorylates forkhead box transcription factors
  findings: []
- id: Reactome:R-HSA-5692779
  title: p-T182 MAPKAPK5 phosphorylates FOXO1
  findings: []
- id: Reactome:R-HSA-5692785
  title: p-S215 FOXO1 binds RAG gene
  findings: []
- id: Reactome:R-HSA-6790036
  title: Expression of STAT3-upregulated nuclear proteins
  findings: []
- id: Reactome:R-HSA-9614414
  title: AKT-phosphorylated FOXO1,FOXO3,FOXO4 translocate to the cytosol
  findings: []
- id: Reactome:R-HSA-9614423
  title: 14-3-3 proteins bind AKT-phosphorylated FOXO1
  findings: []
- id: Reactome:R-HSA-9614662
  title: FOXO1,FOXO3,(FOXO4) bind FASLG gene promoter
  findings: []
- id: Reactome:R-HSA-9617840
  title: FOXO1,FOXO3,FOXO4 bind CDKN1A gene promoter
  findings: []
- id: Reactome:R-HSA-9617996
  title: FOXO1,FOXO3,FOXO4 bind p-2S-SMAD2/3:SMAD4
  findings: []
- id: Reactome:R-HSA-9622980
  title: FOXO1 binds NPY gene promoter
  findings: []
- id: Reactome:R-HSA-9623415
  title: FOXO1,FOXO3,FOXO4 bind IGFBP1 gene promoter
  findings: []
- id: Reactome:R-HSA-9624976
  title: FOXO1,FOXO3 binds CAV1 gene promoter
  findings: []
- id: Reactome:R-HSA-9625091
  title: FOXO1,FOXO3 bind ABCA6 gene promoter
  findings: []
- id: Reactome:R-HSA-9626928
  title: CREBBP binds FOXO1
  findings: []
- id: Reactome:R-NUL-9620806
  title: FOXO1,FOXO3 binds Rbl2 gene
  findings: []
- id: Reactome:R-NUL-9620857
  title: FOXO1,FOXO3 binds Ccng2 gene
  findings: []
- id: Reactome:R-NUL-9624599
  title: FOXO1 binds Fbxo32 gene promoter
  findings: []
- id: Reactome:R-NUL-9625492
  title: FOXO1 and p-2S-Smad2/3:Smad4 bind Mstn gene promoter
  findings: []
- id: Reactome:R-NUL-9625758
  title: FOXO1,FOXO3 and SMAD3 bind Trim63 gene promoter
  findings: []
- id: file:human/FOXO1/FOXO1-deep-research-falcon.md
  title: Deep research report on FOXO1
  findings: []

core_functions:
- molecular_function:
    id: GO:0000981
    label: DNA-binding transcription factor activity, RNA polymerase II-specific
  description: >
    FOXO1 is a sequence-specific DNA-binding transcription factor that binds to
    insulin response
    elements (IRE; 5'-TT[G/A]TTTTG-3') and DAF-16 binding elements (DBE; 5'-TT[G/A]TTTAC-3')
    via its conserved forkhead/winged-helix domain to regulate transcription of
    target genes.
  directly_involved_in:
  - id: GO:0045722
    label: positive regulation of gluconeogenesis
- molecular_function:
    id: GO:0000981
    label: DNA-binding transcription factor activity, RNA polymerase II-specific
  description: >
    FOXO1 is the main downstream effector of insulin signaling through the PI3K-AKT
    pathway.
    Insulin-activated AKT phosphorylates FOXO1 at T24/S256/S319, promoting 14-3-3
    binding,
    nuclear export, and transcriptional inactivation. This represents FOXO1's role
    as the
    transcriptional switch for insulin signaling.
  directly_involved_in:
  - id: GO:0008286
    label: insulin receptor signaling pathway
- molecular_function:
    id: GO:0000981
    label: DNA-binding transcription factor activity, RNA polymerase II-specific
  description: >
    FOXO1 mediates cellular adaptation to oxidative stress by translocating to the
    nucleus
    and activating transcription of antioxidant and stress resistance genes. This
    represents
    one of FOXO1's primary evolved functions alongside metabolic regulation.
  directly_involved_in:
  - id: GO:0034599
    label: cellular response to oxidative stress

proposed_new_terms: []

suggested_questions:
- question: >
    Is there evidence for isoform-specific functions of FOXO1 versus FOXO3/FOXO4
    in specific
    tissues, particularly in hepatic gluconeogenesis versus other metabolic processes?
- question: >
    What is the relative contribution of FOXO1's transcriptional versus non-transcriptional
    (cytoplasmic ATG7 interaction) roles in autophagy regulation?

suggested_experiments:
- description: >
    ChIP-seq comparison of FOXO1 binding sites in fed versus fasted hepatocytes
    to define
    the core gluconeogenic gene regulatory program.
- description: >
    Structure-function analysis of FOXO1 acetylation sites to determine which modifications
    are essential for transcription factor activity versus autophagy induction.